Neurology Today in 5 Thu, 16 Apr 2026 03:05:07 +0000 Thu, 16 Apr 2026 03:05:07 +0000 Libsyn RSSgen 1.0 http://www.neurotodayonline.com en American Academy of Neurology http://www.neurotodayonline.com Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of <em>Neurology Today</em> provides an overview of topics covered in the latest issue. https://static.libsyn.com/p/assets/5/6/b/9/56b99690b144a431e55e3c100dce7605/NTin5_Icon_1400x1400.jpg Neurology Today in 5 Neurology Today no American Academy of Neurology podcast@aan.com episodic neurology no Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of <em>Neurology Today</em> provides an overview of topics covered in the latest issue. Academic Jobs for Fellowship Graduates, Complex Neuromuscular Treatments, New Stroke Guideline Academic Jobs for Fellowship Graduates, Complex Neuromuscular Treatments, New Stroke Guideline Thu, 16 Apr 2026 03:00:00 +0000 In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the academic job market for fellowship graduates, the challenges of today's complex neuromuscular therapies, and the changes made in a new stroke guideline.

]]> In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the academic job market for fellowship graduates, the challenges of today's complex neuromuscular therapies, and the changes made in a new stroke guideline.

]]> 05:12 false full American Academy of Neurology Neurology TodayIn this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the academic job market for fellowship graduates, the challenges of today's complex neuromuscular therapies, and the changes made in a new stroke guideline.In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the academic job market for fellowship graduates, the challenges of today's complex neuromuscular therapies, and the changes made in a new stroke guideline. Acetaminophen Use During Pregnancy, Air Pollution and Motor Neuron Disease, Fremanezumab for Pediatric Migraine Acetaminophen Use During Pregnancy, Air Pollution and Motor Neuron Disease, Fremanezumab for Pediatric Migraine Thu, 02 Apr 2026 03:00:00 +0000 In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about acetaminophen use during pregnancy, the link between air pollution and motor neuron disease risk, and the use of fremanezumab for pediatric migraine.

]]> In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about acetaminophen use during pregnancy, the link between air pollution and motor neuron disease risk, and the use of fremanezumab for pediatric migraine.

]]> 05:06 false full American Academy of Neurology Neurology TodayIn this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about acetaminophen use during pregnancy, the link between air pollution and motor neuron disease risk, and the use of fremanezumab for pediatric migraine.In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about acetaminophen use during pregnancy, the link between air pollution and motor neuron disease risk, and the use of fremanezumab for pediatric migraine. ACGME neurocritical care accreditation, Jamaica hurricane aftermath, rituximab for multiple sclerosis ACGME neurocritical care accreditation, Jamaica hurricane aftermath, rituximab for multiple sclerosis Thu, 19 Mar 2026 03:00:00 +0000 In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about ACGME neurocritical care accreditation, how neurologists in Jamaica are recovering from hurricane damage, and the use of rituximab maintenance dosing in multiple sclerosis.

]]> In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about ACGME neurocritical care accreditation, how neurologists in Jamaica are recovering from hurricane damage, and the use of rituximab maintenance dosing in multiple sclerosis.

]]> 04:46 false full American Academy of Neurology Neurology TodayIn this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about ACGME neurocritical care accreditation, how neurologists in Jamaica are recovering from hurricane damage, and the use of rituximab maintenance dosing in multiple sclerosis.In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about ACGME neurocritical care accreditation, how neurologists in Jamaica are recovering from hurricane damage, and the use of rituximab maintenance dosing in multiple sclerosis. West Nile Neuroinvasive Disease, NINDS Director's Departure, Advanced Practice Provider Educational Funding West Nile Neuroinvasive Disease, NINDS Director's Departure, Advanced Practice Provider Educational Funding Thu, 05 Mar 2026 04:00:00 +0000 In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about West Nile neuroinvasive disease, what's next after NINDS director Dr. Walter Koroshetz's departure, and changes to funding for advanced practice providers' education.

]]> In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about West Nile neuroinvasive disease, what's next after NINDS director Dr. Walter Koroshetz's departure, and changes to funding for advanced practice providers' education.

]]> 05:00 false full American Academy of Neurology Neurology TodayIn this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about West Nile neuroinvasive disease, what's next after NINDS director Dr. Walter Koroshetz's departure, and changes to funding for advanced practice providers' education.In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about West Nile neuroinvasive disease, what's next after NINDS director Dr. Walter Koroshetz's departure, and changes to funding for advanced practice providers' education. EMG Expertise, GLP-1s and Epilepsy, Astrocytoma Combination Therapy EMG Expertise, GLP-1s and Epilepsy, Astrocytoma Combination Therapy Thu, 19 Feb 2026 04:00:00 +0000 In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about EMG expertise, GLP-1s and epilepsy risk reduction, and combination therapy for recurrent IDH-mutant astrocytoma.

]]> In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about EMG expertise, GLP-1s and epilepsy risk reduction, and combination therapy for recurrent IDH-mutant astrocytoma.

]]> 04:38 false full American Academy of Neurology Neurology TodayIn this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about EMG expertise, GLP-1s and epilepsy risk reduction, and combination therapy for recurrent IDH-mutant astrocytoma.In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about EMG expertise, GLP-1s and epilepsy risk reduction, and combination therapy for recurrent IDH-mutant astrocytoma. EMG Expertise, GLP-1s and Epilepsy, Astrocytoma Combination Therapy EMG Expertise, GLP-1s and Epilepsy, Astrocytoma Combination Therapy Thu, 19 Feb 2026 04:00:00 +0000 In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about EMG expertise, GLP-1s and epilepsy risk reduction, and combination therapy for recurrent IDH-mutant astrocytoma.

]]> In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about EMG expertise, GLP-1s and epilepsy risk reduction, and combination therapy for recurrent IDH-mutant astrocytoma.

]]> 04:38 false full American Academy of Neurology Neurology TodayIn this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about EMG expertise, GLP-1s and epilepsy risk reduction, and combination therapy for recurrent IDH-mutant astrocytoma.In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about EMG expertise, GLP-1s and epilepsy risk reduction, and combination therapy for recurrent IDH-mutant astrocytoma. Lasmiditan Discontinuation, DAAN Designation, Alteplase for Eye Stroke Lasmiditan Discontinuation, DAAN Designation, Alteplase for Eye Stroke Thu, 05 Feb 2026 04:00:00 +0000 In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the discontinuation of lasmiditan, the new DAAN designation, and the use of alteplase after eye stroke.

]]> In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the discontinuation of lasmiditan, the new DAAN designation, and the use of alteplase after eye stroke.

]]> 04:44 false full Neurology TodayIn this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the discontinuation of lasmiditan, the new DAAN designation, and the use of alteplase after eye stroke.Neurology TodayIn this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the discontinuation of lasmiditan, the new DAAN designation, and the use of alteplase after eye stroke. Genetic Counselors, Wrist-Worn Stimulation Device for Essential Tremor, CREST-2 Study Results Genetic Counselors, Wrist-Worn Stimulation Device for Essential Tremor, CREST-2 Study Results Thu, 15 Jan 2026 04:00:00 +0000 In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the growing role of genetic counselors in neurology, a wrist-worn stimulation device for essential tremor, and results from the CREST-2 study of asymptomatic carotid disease.

]]> In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the growing role of genetic counselors in neurology, a wrist-worn stimulation device for essential tremor, and results from the CREST-2 study of asymptomatic carotid disease.

]]> 05:09 false full American Academy of Neurology Neurology TodayIn this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the growing role of genetic counselors in neurology, a wrist-worn stimulation device for essential tremor, and results from the CREST-2 study of asymptomatic carotid disease.In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the growing role of genetic counselors in neurology, a wrist-worn stimulation device for essential tremor, and results from the CREST-2 study of asymptomatic carotid disease. Shunt Benefit in iNPH, Downstream Revenue, Anticoagulant Monotherapy Shunt Benefit in iNPH, Downstream Revenue, Anticoagulant Monotherapy Fri, 02 Jan 2026 04:00:00 +0000 In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the benefit of shunts in idiopathic normal-pressure hydrocephalus, how neurologists drive downstream revenue, and anticoagulant monotherapy after stroke.

]]> In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the benefit of shunts in idiopathic normal-pressure hydrocephalus, how neurologists drive downstream revenue, and anticoagulant monotherapy after stroke.

]]> 04:59 false full American Academy of Neurology Neurology TodayIn this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the benefit of shunts in idiopathic normal-pressure hydrocephalus, how neurologists drive downstream revenue, and anticoagulant monotherapy after stroke.In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the benefit of shunts in idiopathic normal-pressure hydrocephalus, how neurologists drive downstream revenue, and anticoagulant monotherapy after stroke. P-tau217 Alzheimer's Blood Test, Tirofiban With Thrombolysis, Artificial Intelligence in Diagnostic Coding P-tau217 Alzheimer's Blood Test, Tirofiban With Thrombolysis, Artificial Intelligence in Diagnostic Coding Thu, 18 Dec 2025 04:00:00 +0000 In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a p-tau217 blood test for Alzheimer's disease, the benefits of tirofiban with thrombolysis, and an AI tool that excels in diagnostic coding.

]]> In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a p-tau217 blood test for Alzheimer's disease, the benefits of tirofiban with thrombolysis, and an AI tool that excels in diagnostic coding.

]]> 04:46 false full American Academy of Neurology Neurology TodayIn this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a p-tau217 blood test for Alzheimer's disease, the benefits of tirofiban with thrombolysis, and an AI tool that excels in diagnostic coding.In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a p-tau217 blood test for Alzheimer's disease, the benefits of tirofiban with thrombolysis, and an AI tool that excels in diagnostic coding. Medical school acceptance, hemorrhagic stroke surgery, brain tumors after TBI Medical school acceptance, hemorrhagic stroke surgery, brain tumors after TBI Thu, 04 Dec 2025 04:00:00 +0000 In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about medical school acceptance rates after the ending of affirmative action, minimally invasive surgery for hemorrhagic stroke, and the increased risk of brain tumors after traumatic brain injury.

]]> In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about medical school acceptance rates after the ending of affirmative action, minimally invasive surgery for hemorrhagic stroke, and the increased risk of brain tumors after traumatic brain injury.

]]> 04:37 false full American Academy of Neurology Neurology TodayIn this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about medical school acceptance rates after the ending of affirmative action, minimally invasive surgery for hemorrhagic stroke, and the increased risk of brain tumors after traumatic brain injury.In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about medical school acceptance rates after the ending of affirmative action, minimally invasive surgery for hemorrhagic stroke, and the increased risk of brain tumors after traumatic brain injury. Artificial sweeteners cognition concerns, drug company payments and prescribing decisions, graphene technology Artificial sweeteners cognition concerns, drug company payments and prescribing decisions, graphene technology Thu, 20 Nov 2025 04:00:00 +0000 In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about artificial sweeteners' impact on cognitive health, how drug company payments influence prescribing decisions, and the use of graphene technology to accelerate maturation of neurons.

]]> In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about artificial sweeteners' impact on cognitive health, how drug company payments influence prescribing decisions, and the use of graphene technology to accelerate maturation of neurons.

]]> 04:46 false full American Academy of Neurology Neurology TodayIn this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about artificial sweeteners' impact on cognitive health, how drug company payments influence prescribing decisions, and the use of graphene technology to accelerate maturation of neurons.In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about artificial sweeteners' impact on cognitive health, how drug company payments influence prescribing decisions, and the use of graphene technology to accelerate maturation of neurons. 50 years of monoclonal antibodies, pregabalin and heart failure, combined therapy for primary progressive aphasia 50 years of monoclonal antibodies, pregabalin and heart failure, combined therapy for primary progressive aphasia Thu, 06 Nov 2025 04:00:00 +0000 In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about how monoclonal antibodies revolutionized neurologic treatment, why pregabalin link to increased heart failure, and a combined therapy that slows progression in primary progressive aphasia.

]]> In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about how monoclonal antibodies revolutionized neurologic treatment, why pregabalin link to increased heart failure, and a combined therapy that slows progression in primary progressive aphasia.

]]> 04:24 false full American Academy of Neurology Neurology TodayIn this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about how monoclonal antibodies revolutionized neurologic treatment, why pregabalin link to increased heart failure, and a combined therapy that slows progression in primary progressive aphasia.In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about how monoclonal antibodies revolutionized neurologic treatment, why pregabalin link to increased heart failure, and a combined therapy that slows progression in primary progressive aphasia. Novel PET radiotracer, GLP-1s and dementia risk, green space benefits Novel PET radiotracer, GLP-1s and dementia risk, green space benefits Thu, 16 Oct 2025 03:00:00 +0000 In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a PET radiotracer that shows intranasally delivered insulin enters the brain, GLP-1s and dementia risk in people with Type 2 diabetes, and how exposure to green space may reduce the risk of neurodevelopmental delays in children.

]]> In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a PET radiotracer that shows intranasally delivered insulin enters the brain, GLP-1s and dementia risk in people with Type 2 diabetes, and how exposure to green space may reduce the risk of neurodevelopmental delays in children.

]]> 04:49 false full American Academy of Neurology Neurology TodayIn this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a PET radiotracer that shows intranasally delivered insulin enters the brain, GLP-1s and dementia risk in people with Type 2 diabetes, and how exposure to green space may reduce the risk of neurodevelopmental delays in children.In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a PET radiotracer that shows intranasally delivered insulin enters the brain, GLP-1s and dementia risk in people with Type 2 diabetes, and how exposure to green space may reduce the risk of neurodevelopmental delays in children. Pegivirus' role in Parkinson's disease, GLP-1s and idiopathic intracranial hypertension, geographic spread of epilepsy specialists Pegivirus' role in Parkinson's disease, GLP-1s and idiopathic intracranial hypertension, geographic spread of epilepsy specialists Thu, 02 Oct 2025 03:00:00 +0000 In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about pegivirus's potential role in Parkinson's disease pathology, the impact of GLP-1 receptor agonistst on idiopathic intracranial hypertension, and the geographic spread of epilepsy specialists.

]]> In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about pegivirus's potential role in Parkinson's disease pathology, the impact of GLP-1 receptor agonistst on idiopathic intracranial hypertension, and the geographic spread of epilepsy specialists.

]]> 04:59 false full American Academy of Neurology Neurology TodayIn this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about pegivirus's potential role in Parkinson's disease pathology, the impact of GLP-1 receptor agonistst on idiopathic intracranial hypertension, and the geographic spread of epilepsy specialists.In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about pegivirus's potential role in Parkinson's disease pathology, the impact of GLP-1 receptor agonistst on idiopathic intracranial hypertension, and the geographic spread of epilepsy specialists. Food deserts and stroke risk, physical activity in Parkinson's disease, rimegepant for migraine Food deserts and stroke risk, physical activity in Parkinson's disease, rimegepant for migraine Thu, 18 Sep 2025 03:00:00 +0000 In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the relationship between income, "food deserts," and stroke risk; why staying active may reduce cognitive decline in patients with Parkinson's disease; and how initiating rimegepant for migraine could help reduce opioid and butalbital use. 

]]> In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the relationship between income, "food deserts," and stroke risk; why staying active may reduce cognitive decline in patients with Parkinson's disease; and how initiating rimegepant for migraine could help reduce opioid and butalbital use.

]]> 04:51 false full American Academy of Neurology Neurology TodayIn this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the relationship between income, "food deserts," and stroke risk; why staying active may reduce cognitive decline in patients with Parkinson's disease; and how initiating rimegepant for migraine could help reduce opioid and butalbital use. In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the relationship between income, "food deserts," and stroke risk; why staying active may reduce cognitive decline in patients with Parkinson's disease; and how initiating rimegepant for migraine could help reduce opioid and butalbital use.  Parkinson's and dementia with Lewy bodies blood test, CAR T-cell therapy for glioblastoma, wireless EEG Parkinson's and dementia with Lewy bodies blood test, CAR T-cell therapy for glioblastoma, wireless EEG Thu, 04 Sep 2025 03:00:00 +0000 In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a promising blood test to distinguish Parkinson's disease from dementia with Lewy bodies, how CAR T-cell therapies are showing potential for patients with glioblastoma, and a new wireless electroencephalogram device that can even monitor young children with epilepsy.

]]> In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a promising blood test to distinguish Parkinson's disease from dementia with Lewy bodies, how CAR T-cell therapies are showing potential for patients with glioblastoma, and a new wireless electroencephalogram device that can even monitor young children with epilepsy.

]]> 04:27 false full American Academy of Neurology Neurology TodayIn this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a promising blood test to distinguish Parkinson's disease from dementia with Lewy bodies, how CAR T-cell therapies are showing potential for patients with glioblastoma, and a new wireless electroencephalogram device that can even monitor young children with epilepsy.In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a promising blood test to distinguish Parkinson's disease from dementia with Lewy bodies, how CAR T-cell therapies are showing potential for patients with glioblastoma, and a new wireless electroencephalogram device that can even monitor young children with epilepsy. Small fiber neuropathy, Dr. Merit Cudkowicz, work-life balance for families of neurologists Small fiber neuropathy, Dr. Merit Cudkowicz, work-life balance for families of neurologists Thu, 21 Aug 2025 03:00:00 +0000 In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about whether small fiber neuropathy is an autoimmune disorder; Merit Cudkowicz, MD, MSc, FAAN, recipient of this year's AAN Lifetime Achievement Award for Clinically Relevant Research; and how neurologist couples pursue work-life balance.

]]> In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about whether small fiber neuropathy is an autoimmune disorder; Merit Cudkowicz, MD, MSc, FAAN, recipient of this year's AAN Lifetime Achievement Award for Clinically Relevant Research; and how neurologist couples pursue work-life balance.

]]> 03:52 false full American Academy of Neurology Neurology TodayIn this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about whether small fiber neuropathy is an autoimmune disorder; Merit Cudkowicz, MD, MSc, FAAN, recipient of this year's AAN Lifetime Achievement Award for Clinically Relevant Research; and how neurologist couples pursue work-life balance.In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about whether small fiber neuropathy is an autoimmune disorder; Merit Cudkowicz, MD, MSc, FAAN, recipient of this year's AAN Lifetime Achievement Award for Clinically Relevant Research; and how neurologist couples pursue work-life balance. Divisive treatment for cluster headache, head positioning before thrombectomy, new series, "Neurology in America" Divisive treatment for cluster headache, head positioning before thrombectomy, new series, "Neurology in America" Thu, 07 Aug 2025 03:00:00 +0000 In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about eptinezumab, a treatment for episodic cluster headache; how positioning the head flat before a thrombectomy benefited patients with large vessel occlusion stroke; and what rural neurology looks like in 2025, the first story in our new series, Neurology in America.

]]> In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about eptinezumab, a treatment for episodic cluster headache; how positioning the head flat before a thrombectomy benefited patients with large vessel occlusion stroke; and what rural neurology looks like in 2025, the first story in our new series, Neurology in America.

]]> 04:10 false full American Academy of Neurology Neurology TodayIn this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about eptinezumab, a treatment for episodic cluster headache; how positioning the head flat before a thrombectomy benefited patients with large vessel occlusion stroke; and what rural neurology looks like in 2025, the first story in our new series, Neurology in America.In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about eptinezumab, a treatment for episodic cluster headache; how positioning the head flat before a thrombectomy benefited patients with large vessel occlusion stroke; and what rural neurology looks like in 2025, the first story in our new series, Neurology in America. New treatment for giant-cell arteritis, links between oral and brain health, an emerging meningitis B vaccine New treatment for giant-cell arteritis, links between oral and brain health, an emerging meningitis B vaccine Thu, 17 Jul 2025 03:00:00 +0000 In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about upadacitinib, a new treatment for giant-cell arteritis; growing evidence linking oral health to a higher risk of neurologic conditions; and why a trial of a new meningitis B vaccine drew a mixed response.

]]> In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about upadacitinib, a new treatment for giant-cell arteritis; growing evidence linking oral health to a higher risk of neurologic conditions; and why a trial of a new meningitis B vaccine drew a mixed response.

]]> 04:34 false full American Academy of Neurology Neurology TodayIn this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about upadacitinib, a new treatment for giant-cell arteritis; growing evidence linking oral health to a higher risk of neurologic conditions; and why a trial of a new meningitis B vaccine drew a mixed response.In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about upadacitinib, a new treatment for giant-cell arteritis; growing evidence linking oral health to a higher risk of neurologic conditions; and why a trial of a new meningitis B vaccine drew a mixed response. Telomere length and and risk for neurologic disorders, impact of research cuts on promotion/tenure, herpes zoster vaccine and dementia Telomere length and and risk for neurologic disorders, impact of research cuts on promotion/tenure, herpes zoster vaccine and dementia Thu, 03 Jul 2025 03:00:00 +0000 In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles on the association of shortened telomeres on risk for stroke, late-life depression and dementia; affect of research funding cuts on tenure/promotion opportunities; and  herpes zoster vaccine and reduced dementia risk.

]]> In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles on the association of shortened telomeres on risk for stroke, late-life depression and dementia; affect of research funding cuts on tenure/promotion opportunities; and herpes zoster vaccine and reduced dementia risk.

]]> 04:51 false full American Academy of Neurology Neurology TodayIn this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles on the association of shortened telomeres on risk for stroke, late-life depression and dementia; affect of research funding cuts on tenure/promotion opportunities; and  herpes zoster vaccine and reduced dementia risk.In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles on the association of shortened telomeres on risk for stroke, late-life depression and dementia; affect of research funding cuts on tenure/promotion opportunities; and  herpes zoster vaccine and reduced dementia risk. Post-TIA fatigue, neurologic complications of measles, CDC surveillance of epilepsy program dismantled. Post-TIA fatigue, neurologic complications of measles, CDC surveillance of epilepsy program dismantled. Thu, 19 Jun 2025 03:00:00 +0000 In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles studies showing persistent fatigue after TIA, the neurologic complications of measles, and the impact of the dismantling of a CDC surveillance program of epilepsy.

]]> In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles studies showing persistent fatigue after TIA, the neurologic complications of measles, and the impact of the dismantling of a CDC surveillance program of epilepsy.

]]> 04:14 false full American Academy of Neurology Neurology TodayIn this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles studies showing persistent fatigue after TIA, the neurologic complications of measles, and the impact of the dismantling of a CDC surveillance program of epilepsy.In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles studies showing persistent fatigue after TIA, the neurologic complications of measles, and the impact of the dismantling of a CDC surveillance program of epilepsy. Post-TIA fatigue, neurologic complications of measles, CDC surveillance of epilepsy program dismantled. Post-TIA fatigue, neurologic complications of measles, CDC surveillance of epilepsy program dismantled. Thu, 05 Jun 2025 03:00:00 +0000 In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles studies showing persistent fatigue after TIA, the neurologic complications of measles, and the impact of the dismantling of a CDC surveillance program of epilepsy.

]]> In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles studies showing persistent fatigue after TIA, the neurologic complications of measles, and the impact of the dismantling of a CDC surveillance program of epilepsy.

]]> 04:27 false full American Academy of Neurology Neurology TodayIn this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles studies showing persistent fatigue after TIA, the neurologic complications of measles, and the impact of the dismantling of a CDC surveillance program of epilepsy.In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles studies showing persistent fatigue after TIA, the neurologic complications of measles, and the impact of the dismantling of a CDC surveillance program of epilepsy. Advances in cell therapies for Parkinson's, GLP-1 agonists and dementia risk, FDA accelerated approvals for neurology drugs Advances in cell therapies for Parkinson's, GLP-1 agonists and dementia risk, FDA accelerated approvals for neurology drugs Thu, 15 May 2025 03:00:00 +0000 In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about early studies finding dopamine cellular therapies were safe and tolerable for patients with Parkinson's, use of GLP-1 agonists were associated with reduced dementia risks, and the FDA use of accelerated approvals for several neurology drugs are under scrutiny. 

]]> In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about early studies finding dopamine cellular therapies were safe and tolerable for patients with Parkinson's, use of GLP-1 agonists were associated with reduced dementia risks, and the FDA use of accelerated approvals for several neurology drugs are under scrutiny.

]]> 04:14 false full American Academy of Neurology Neurology TodayIn this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about early studies finding dopamine cellular therapies were safe and tolerable for patients with Parkinson's, use of GLP-1 agonists were associated with reduced dementia risks, and the FDA use of accelerated approvals for several neurology drugs are under scrutiny. In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about early studies finding dopamine cellular therapies were safe and tolerable for patients with Parkinson's, use of GLP-1 agonists were associated with reduced dementia risks, and the FDA use of accelerated approvals for several neurology drugs are under scrutiny.  Microplastics in brain, salary gap in neurology, the neurology of space Microplastics in brain, salary gap in neurology, the neurology of space Thu, 01 May 2025 03:00:00 +0000 In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles finding microplastics in the brain postmortem linked to dementia, the salary gap between men and women neurologies, and neurologists studying the impact of microgravity on the brain.

]]> In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles finding microplastics in the brain postmortem linked to dementia, the salary gap between men and women neurologies, and neurologists studying the impact of microgravity on the brain.

]]> 04:16 false full American Academy of Neurology Neurology TodayIn this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles finding microplastics in the brain postmortem linked to dementia, the salary gap between men and women neurologies, and neurologists studying the impact of microgravity on the brain.In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles finding microplastics in the brain postmortem linked to dementia, the salary gap between men and women neurologies, and neurologists studying the impact of microgravity on the brain. Impact of high-dose Vitamin D on MS relapse, the role of AI in neurology education, and a 4D animal model that shows precursors of MS lesions before they appear. Impact of high-dose Vitamin D on MS relapse, the role of AI in neurology education, and a 4D animal model that shows precursors of MS lesions before they appear. Thu, 17 Apr 2025 03:00:00 +0000 In this episodeof Neurology Today in 5, Neurology Today editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a large trial that found high-dose Vitamin D reduced MRI evidence of disease activity in patients with clinically isolated syndrome or early relapsing MS; an animal brain map, revealing changes in inflammation, immune activity, and cell repair that preceded the appearance of MS lesions; and a discussion of the challenges and opportunities of using AI in neurology education.

]]> In this episodeof Neurology Today in 5, Neurology Today editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a large trial that found high-dose Vitamin D reduced MRI evidence of disease activity in patients with clinically isolated syndrome or early relapsing MS; an animal brain map, revealing changes in inflammation, immune activity, and cell repair that preceded the appearance of MS lesions; and a discussion of the challenges and opportunities of using AI in neurology education.

]]> 04:41 false full American Academy of Neurology Neurology TodayIn this episodeof Neurology Today in 5, Neurology Today editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a large trial that found high-dose Vitamin D reduced MRI evidence of disease activity in patients with clinically isolated syndrome or early relapsing MS; an animal brain map, revealing changes in inflammation, immune activity, and cell repair that preceded the appearance of MS lesions; and a discussion of the challenges and opportunities of using AI in neurology education.In this episodeof Neurology Today in 5, Neurology Today editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a large trial that found high-dose Vitamin D reduced MRI evidence of disease activity in patients with clinically isolated syndrome or early relapsing MS; an animal brain map, revealing changes in inflammation, immune activity, and cell repair that preceded the appearance of MS lesions; and a discussion of the challenges and opportunities of using AI in neurology education. New approved drug for neurofibromatosis 1 with plexiform neurofibromas, multidisciplinary clinics in neurology, impact of cuts to DEI research grants New approved drug for neurofibromatosis 1 with plexiform neurofibromas, multidisciplinary clinics in neurology, impact of cuts to DEI research grants Thu, 03 Apr 2025 09:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief highlights articles on the newly approved drug for neurofibromatosis 1 with plexiform neuromas in adults, how neurology practices are integrating with multiple subspecialties, and the impact of federal cuts to DEI grants and research.

]]> In this week's podcast, Neurology Today's editor-in-chief highlights articles on the newly approved drug for neurofibromatosis 1 with plexiform neuromas in adults, how neurology practices are integrating with multiple subspecialties, and the impact of federal cuts to DEI grants and research.

]]> 04:35 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief highlights articles on the newly approved drug for neurofibromatosis 1 with plexiform neuromas in adults, how neurology practices are integrating with multiple subspecialties, and the impact of federal cuts to DEI grants and research.In this week's podcast, Neurology Today's editor-in-chief highlights articles on the newly approved drug for neurofibromatosis 1 with plexiform neuromas in adults, how neurology practices are integrating with multiple subspecialties, and the impact of federal cuts to DEI grants and research. Impact of NIH cuts on neurology research, response to ACP's guideline on migraine, an updated position on seizures, driver licensure, and medical reporting Impact of NIH cuts on neurology research, response to ACP's guideline on migraine, an updated position on seizures, driver licensure, and medical reporting Thu, 20 Mar 2025 03:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief highlights articles on the impact of NIH cuts to indirect research costs, response to a new guideline on migraine prevention from ACP, and an updated position statement from the AAN on seizures, driver licensures, and medical reporting.

]]> In this week's podcast, Neurology Today's editor-in-chief highlights articles on the impact of NIH cuts to indirect research costs, response to a new guideline on migraine prevention from ACP, and an updated position statement from the AAN on seizures, driver licensures, and medical reporting.

]]> 05:06 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief highlights articles on the impact of NIH cuts to indirect research costs, response to a new guideline on migraine prevention from ACP, and an updated position statement from the AAN on seizures, driver licensures, and medical reporting.In this week's podcast, Neurology Today's editor-in-chief highlights articles on the impact of NIH cuts to indirect research costs, response to a new guideline on migraine prevention from ACP, and an updated position statement from the AAN on seizures, driver licensures, and medical reporting. Lifetime burden of dementia, hidden features on EEGs for epilepsy detection, neurology-trained pharmacists Lifetime burden of dementia, hidden features on EEGs for epilepsy detection, neurology-trained pharmacists Thu, 06 Mar 2025 04:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief highlights articles on the larger lifetime burden of dementia than projected, an AI-fueled program that detects hidden features in EEGs for epilepsy detection, and neurology-trained pharmacists who are working with neurology departments.

]]> In this week's podcast, Neurology Today's editor-in-chief highlights articles on the larger lifetime burden of dementia than projected, an AI-fueled program that detects hidden features in EEGs for epilepsy detection, and neurology-trained pharmacists who are working with neurology departments.

]]> 04:44 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief highlights articles on the larger lifetime burden of dementia than projected, an AI-fueled program that detects hidden features in EEGs for epilepsy detection, and neurology-trained pharmacists who are working with neurology departments.In this week's podcast, Neurology Today's editor-in-chief highlights articles on the larger lifetime burden of dementia than projected, an AI-fueled program that detects hidden features in EEGs for epilepsy detection, and neurology-trained pharmacists who are working with neurology departments. IVF and MS relapse, community-based neurologists doing clinical research, and the loneliness protein implicated in brain function. IVF and MS relapse, community-based neurologists doing clinical research, and the loneliness protein implicated in brain function. Thu, 20 Feb 2025 04:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief highlights articles on new data on IVF safety for women with MS, an elevated protein associated with loneliness, social isolation and brain function, and the role of community-based neurologists in drug development.  

]]> In this week's podcast, Neurology Today's editor-in-chief highlights articles on new data on IVF safety for women with MS, an elevated protein associated with loneliness, social isolation and brain function, and the role of community-based neurologists in drug development.

]]> 05:25 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief highlights articles on new data on IVF safety for women with MS, an elevated protein associated with loneliness, social isolation and brain function, and the role of community-based neurologists in drug development.  In this week's podcast, Neurology Today's editor-in-chief highlights articles on new data on IVF safety for women with MS, an elevated protein associated with loneliness, social isolation and brain function, and the role of community-based neurologists in drug development.   Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment Thu, 06 Feb 2025 04:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief highlights articles on the pros and cons of virtual neurology education, the FDA approval of tirzepatide for obesity-related obstructive sleep apnea, and the promise of AI for glioma assessment.  

]]> In this week's podcast, Neurology Today's editor-in-chief highlights articles on the pros and cons of virtual neurology education, the FDA approval of tirzepatide for obesity-related obstructive sleep apnea, and the promise of AI for glioma assessment.

]]> 04:49 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief highlights articles on the pros and cons of virtual neurology education, the FDA approval of tirzepatide for obesity-related obstructive sleep apnea, and the promise of AI for glioma assessment.  In this week's podcast, Neurology Today's editor-in-chief highlights articles on the pros and cons of virtual neurology education, the FDA approval of tirzepatide for obesity-related obstructive sleep apnea, and the promise of AI for glioma assessment.   Middle meningeal artery embolization and subdural hematoma, processed red meat and dementia risk, and editor picks for best neurology advances of 2024. Middle meningeal artery embolization and subdural hematoma, processed red meat and dementia risk, and editor picks for best neurology advances of 2024. Thu, 16 Jan 2025 04:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief highlights articles on the safety of middle meningeal artery embolization for chronic subdural hematoma, the processed red meat and risk for dementia, and editors' picks for the best advances of 2024.

]]> In this week's podcast, Neurology Today's editor-in-chief highlights articles on the safety of middle meningeal artery embolization for chronic subdural hematoma, the processed red meat and risk for dementia, and editors' picks for the best advances of 2024.

]]> 04:24 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief highlights articles on the safety of middle meningeal artery embolization for chronic subdural hematoma, the processed red meat and risk for dementia, and editors' picks for the best advances of 2024.In this week's podcast, Neurology Today's editor-in-chief highlights articles on the safety of middle meningeal artery embolization for chronic subdural hematoma, the processed red meat and risk for dementia, and editors' picks for the best advances of 2024. Magnesium sulfate for cerebral palsy, novel gene therapy for muscular dystrophies, chronic traumatic encephalitis and suicidality in retired NFL players. Magnesium sulfate for cerebral palsy, novel gene therapy for muscular dystrophies, chronic traumatic encephalitis and suicidality in retired NFL players. Thu, 02 Jan 2025 04:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief highlights articles on the latest Cochrane review of magnesium sulfate to prevent cerebral palsy; a novel mRNA system for gene therapy for muscular dystrophies, and the perception of CTE and suicidality risk in retired NFL players. 

]]> In this week's podcast, Neurology Today's editor-in-chief highlights articles on the latest Cochrane review of magnesium sulfate to prevent cerebral palsy; a novel mRNA system for gene therapy for muscular dystrophies, and the perception of CTE and suicidality risk in retired NFL players.

]]> 04:59 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief highlights articles on the latest Cochrane review of magnesium sulfate to prevent cerebral palsy; a novel mRNA system for gene therapy for muscular dystrophies, and the perception of CTE and suicidality risk in retired NFL players. In this week's podcast, Neurology Today's editor-in-chief highlights articles on the latest Cochrane review of magnesium sulfate to prevent cerebral palsy; a novel mRNA system for gene therapy for muscular dystrophies, and the perception of CTE and suicidality risk in retired NFL players.  Revised criteria for diagnosing MS, AI for alleviating administrative burden, neonatal neurocritical care as a growing subspecialty Revised criteria for diagnosing MS, AI for alleviating administrative burden, neonatal neurocritical care as a growing subspecialty Thu, 19 Dec 2024 04:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief highlights articles on proposed updated criteria for diagnosing MS before symptoms manifest, the use of large language models to address administrative burden with electronic medical records, and the growth of training programs in neonatal neurocritical care.

]]> In this week's podcast, Neurology Today's editor-in-chief highlights articles on proposed updated criteria for diagnosing MS before symptoms manifest, the use of large language models to address administrative burden with electronic medical records, and the growth of training programs in neonatal neurocritical care.

]]> 05:20 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief highlights articles on proposed updated criteria for diagnosing MS before symptoms manifest, the use of large language models to address administrative burden with electronic medical records, and the growth of training programs in neonatal neurocritical care.In this week's podcast, Neurology Today's editor-in-chief highlights articles on proposed updated criteria for diagnosing MS before symptoms manifest, the use of large language models to address administrative burden with electronic medical records, and the growth of training programs in neonatal neurocritical care. 3-year outcomes for anti-NMDAR encephalitis, skin biopsies for diagnosis of human prion diseases, the career benefits of graduate degrees in public health and/or business administration 3-year outcomes for anti-NMDAR encephalitis, skin biopsies for diagnosis of human prion diseases, the career benefits of graduate degrees in public health and/or business administration Thu, 05 Dec 2024 04:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief highlights articles on a study highlighting three-year outcomes for patients with anti-NMDAR encephalitis, an analysis comparing the diagnostic efficacy of skin biopsies vs. CSF tests for human prion diseases, and the ways in which a graduate degree in public health and/or business administration can shape career pathways for neurologists.  

]]> In this week's podcast, Neurology Today's editor-in-chief highlights articles on a study highlighting three-year outcomes for patients with anti-NMDAR encephalitis, an analysis comparing the diagnostic efficacy of skin biopsies vs. CSF tests for human prion diseases, and the ways in which a graduate degree in public health and/or business administration can shape career pathways for neurologists.

]]> 05:02 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief highlights articles on a study highlighting three-year outcomes for patients with anti-NMDAR encephalitis, an analysis comparing the diagnostic efficacy of skin biopsies vs. CSF tests for human prion diseases, and the ways in which a graduate degree in public health and/or business administration can shape career pathways for neurologists.  In this week's podcast, Neurology Today's editor-in-chief highlights articles on a study highlighting three-year outcomes for patients with anti-NMDAR encephalitis, an analysis comparing the diagnostic efficacy of skin biopsies vs. CSF tests for human prion diseases, and the ways in which a graduate degree in public health and/or business administration can shape career pathways for neurologists.   Cardiovascular effects of antiseizure therapies, social determinants of health on children with MS, coverage for blood-based biomarkers for Alzheimer's Cardiovascular effects of antiseizure therapies, social determinants of health on children with MS, coverage for blood-based biomarkers for Alzheimer's Thu, 21 Nov 2024 04:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief highlights articles on the higher risk for cardiovascular effects with certain antiseizure therapies on adults with epilepsy, the impact of social determinants of health on children with MS, and the status of coverage for blood-based tests for Alzheimer's disease.

]]> In this week's podcast, Neurology Today's editor-in-chief highlights articles on the higher risk for cardiovascular effects with certain antiseizure therapies on adults with epilepsy, the impact of social determinants of health on children with MS, and the status of coverage for blood-based tests for Alzheimer's disease.

]]> 04:40 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief highlights articles on the higher risk for cardiovascular effects with certain antiseizure therapies on adults with epilepsy, the impact of social determinants of health on children with MS, and the status of coverage for blood-based tests for Alzheimer's disease.In this week's podcast, Neurology Today's editor-in-chief highlights articles on the higher risk for cardiovascular effects with certain antiseizure therapies on adults with epilepsy, the impact of social determinants of health on children with MS, and the status of coverage for blood-based tests for Alzheimer's disease. Fever prevention and stroke, environmental toxins and Parkinson's, cholesterol overload and ALS progression Fever prevention and stroke, environmental toxins and Parkinson's, cholesterol overload and ALS progression Thu, 07 Nov 2024 04:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief highlights articles on fever prevention and stroke outcomes, the impact of air pollution and other environmental toxins on Parkinson's, and the role of cholesterol overload in ALS progression and disease risk.

]]> In this week's podcast, Neurology Today's editor-in-chief highlights articles on fever prevention and stroke outcomes, the impact of air pollution and other environmental toxins on Parkinson's, and the role of cholesterol overload in ALS progression and disease risk.

]]> 04:20 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief highlights articles on fever prevention and stroke outcomes, the impact of air pollution and other environmental toxins on Parkinson's, and the role of cholesterol overload in ALS progression and disease risk.In this week's podcast, Neurology Today's editor-in-chief highlights articles on fever prevention and stroke outcomes, the impact of air pollution and other environmental toxins on Parkinson's, and the role of cholesterol overload in ALS progression and disease risk. Blood test for ALS, new migraine target reduces headache days, latest data on eculizumab for neuromyelitis optica spectrum disorder Blood test for ALS, new migraine target reduces headache days, latest data on eculizumab for neuromyelitis optica spectrum disorder Thu, 17 Oct 2024 03:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief highlights articles on the potential of a new blood biomarker for ALS, a PACP-targeted migraine therapy, and a real-world review of data on eculizumab for neuromyelitis optica spectrum disorder.

This Podcast is being Sponsored by LocumTenens.com

]]> In this week's podcast, Neurology Today's editor-in-chief highlights articles on the potential of a new blood biomarker for ALS, a PACP-targeted migraine therapy, and a real-world review of data on eculizumab for neuromyelitis optica spectrum disorder.

This Podcast is being Sponsored by LocumTenens.com

]]> 04:41 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief highlights articles on the potential of a new blood biomarker for ALS, a PACP-targeted migraine therapy, and a real-world review of data on eculizumab for neuromyelitis optica spectrum disorder. This Podcast is being Sponsored by LocumTenens.comIn this week's podcast, Neurology Today's editor-in-chief highlights articles on the potential of a new blood biomarker for ALS, a PACP-targeted migraine therapy, and a real-world review of data on eculizumab for neuromyelitis optica spectrum disorder. This Podcast is being Sponsored by LocumTenens.com Eastern equine encephalitis, systems for anti-amyloid therapies, new protocol for eye stroke Eastern equine encephalitis, systems for anti-amyloid therapies, new protocol for eye stroke Thu, 03 Oct 2024 03:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief highlights articles on Eastern equine encephalitis relief, systems developed to meet demand for anti-amyloid therapies, and a new protocol for timely diagnosis and treatment for eye stroke in the emergency department.

This Podcast is being Sponsored by LocumTenens.com

]]> In this week's podcast, Neurology Today's editor-in-chief highlights articles on Eastern equine encephalitis relief, systems developed to meet demand for anti-amyloid therapies, and a new protocol for timely diagnosis and treatment for eye stroke in the emergency department.

This Podcast is being Sponsored by LocumTenens.com

]]> 04:32 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief highlights articles on Eastern equine encephalitis relief, systems developed to meet demand for anti-amyloid therapies, and a new protocol for timely diagnosis and treatment for eye stroke in the emergency department. This Podcast is being Sponsored by LocumTenens.comIn this week's podcast, Neurology Today's editor-in-chief highlights articles on Eastern equine encephalitis relief, systems developed to meet demand for anti-amyloid therapies, and a new protocol for timely diagnosis and treatment for eye stroke in the emergency department. This Podcast is being Sponsored by LocumTenens.com Brain circuit underlying placebo pain relief, common Parkinson's gene variants, blood biomarker testing for Alzheimer's Brain circuit underlying placebo pain relief, common Parkinson's gene variants, blood biomarker testing for Alzheimer's Thu, 19 Sep 2024 03:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief highlights new findings on brain pathways in placebo pain relief, that Parkinson's gene variants are more common than thought, and why there is momentum behind new blood biomarker tests for Alzheimer's.

]]> In this week's podcast, Neurology Today's editor-in-chief highlights new findings on brain pathways in placebo pain relief, that Parkinson's gene variants are more common than thought, and why there is momentum behind new blood biomarker tests for Alzheimer's.

]]> 04:46 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief highlights new findings on brain pathways in placebo pain relief, that Parkinson's gene variants are more common than thought, and why there is momentum behind new blood biomarker tests for Alzheimer's.In this week's podcast, Neurology Today's editor-in-chief highlights new findings on brain pathways in placebo pain relief, that Parkinson's gene variants are more common than thought, and why there is momentum behind new blood biomarker tests for Alzheimer's. Alzheimer's diagnosis criteria, AI and Parkinson's severity, neurotoxicity of racism Alzheimer's diagnosis criteria, AI and Parkinson's severity, neurotoxicity of racism Thu, 05 Sep 2024 03:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief highlights a new workgroup's recommendations on biomarkers for diagnosing Alzheimer's, AI's ability to track Parkinson's severity from brief videos, and the latest research on how racism leads to neural changes and accelerated aging.

]]> In this week's podcast, Neurology Today's editor-in-chief highlights a new workgroup's recommendations on biomarkers for diagnosing Alzheimer's, AI's ability to track Parkinson's severity from brief videos, and the latest research on how racism leads to neural changes and accelerated aging.

]]> 05:04 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief highlights a new workgroup's recommendations on biomarkers for diagnosing Alzheimer's, AI's ability to track Parkinson's severity from brief videos, and the latest research on how racism leads to neural changes and accelerated aging.In this week's podcast, Neurology Today's editor-in-chief highlights a new workgroup's recommendations on biomarkers for diagnosing Alzheimer's, AI's ability to track Parkinson's severity from brief videos, and the latest research on how racism leads to neural changes and accelerated aging. Weight loss drugs and optic neuropathy, normothermic regional perfusion, APPs in neurology practice Weight loss drugs and optic neuropathy, normothermic regional perfusion, APPs in neurology practice Thu, 15 Aug 2024 03:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses data on the association between weight loss drugs and a rare type of optic neuropathy, ethical issues around normothermic regional perfusion, and how neurologists are onboarding and training advanced practice practitioners in comorbid cancer and stroke.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses data on the association between weight loss drugs and a rare type of optic neuropathy, ethical issues around normothermic regional perfusion, and how neurologists are onboarding and training advanced practice practitioners in comorbid cancer and stroke.

]]> 05:22 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses data on the association between weight loss drugs and a rare type of optic neuropathy, ethical issues around normothermic regional perfusion, and how neurologists are onboarding and training advanced practice practitioners in comorbid cancer and stroke.In this week's podcast, Neurology Today's editor-in-chief discusses data on the association between weight loss drugs and a rare type of optic neuropathy, ethical issues around normothermic regional perfusion, and how neurologists are onboarding and training advanced practice practitioners in comorbid cancer and stroke. Body composition and neurologic disease, Tenecteplase and stroke related-disability, comorbid stroke and cancer Body composition and neurologic disease, Tenecteplase and stroke related-disability, comorbid stroke and cancer Wed, 31 Jul 2024 03:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses data on the complex interaction between body composition, vascular health, and neurodegenerative disease, Tenecteplase in an extended treatment window and stroke-related disability, and gene expression in cormorbid cancer and stroke.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses data on the complex interaction between body composition, vascular health, and neurodegenerative disease, Tenecteplase in an extended treatment window and stroke-related disability, and gene expression in cormorbid cancer and stroke.

]]> 05:12 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses data on the complex interaction between body composition, vascular health, and neurodegenerative disease, Tenecteplase in an extended treatment window and stroke-related disability, and gene expression in cormorbid cancer and stroke.In this week's podcast, Neurology Today's editor-in-chief discusses data on the complex interaction between body composition, vascular health, and neurodegenerative disease, Tenecteplase in an extended treatment window and stroke-related disability, and gene expression in cormorbid cancer and stroke. Antihypertensive and reduced risk for epilepsy, first responders to 9-11 and early dementia risk, FDA approval of donanemab Antihypertensive and reduced risk for epilepsy, first responders to 9-11 and early dementia risk, FDA approval of donanemab Thu, 18 Jul 2024 03:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses data on an angiotensin receptor for blocker for hypertension associated with reduced risk for epilepsy, a study finding first responders to 9-11 clean-up sites had an increased risk for early dementia, and dementia experts comment on approval of donanemab.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses data on an angiotensin receptor for blocker for hypertension associated with reduced risk for epilepsy, a study finding first responders to 9-11 clean-up sites had an increased risk for early dementia, and dementia experts comment on approval of donanemab.

]]> 05:17 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses data on an angiotensin receptor for blocker for hypertension associated with reduced risk for epilepsy, a study finding first responders to 9-11 clean-up sites had an increased risk for early dementia, and dementia experts comment on approval of donanemab.In this week's podcast, Neurology Today's editor-in-chief discusses data on an angiotensin receptor for blocker for hypertension associated with reduced risk for epilepsy, a study finding first responders to 9-11 clean-up sites had an increased risk for early dementia, and dementia experts comment on approval of donanemab. Rescue therapies when endovascular thrombectomy fails, the impact of first-seizure clinics on outcomes, AI and sleep neurology Rescue therapies when endovascular thrombectomy fails, the impact of first-seizure clinics on outcomes, AI and sleep neurology Thu, 04 Jul 2024 03:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses data on the effectiveness of rescue therapies when endovascular thrombectomy fails, how first-seizure clinics reduce hospitalizations, and AI's use in sleep neurology.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses data on the effectiveness of rescue therapies when endovascular thrombectomy fails, how first-seizure clinics reduce hospitalizations, and AI's use in sleep neurology.

]]> 05:10 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses data on the effectiveness of rescue therapies when endovascular thrombectomy fails, how first-seizure clinics reduce hospitalizations, and AI's use in sleep neurology.In this week's podcast, Neurology Today's editor-in-chief discusses data on the effectiveness of rescue therapies when endovascular thrombectomy fails, how first-seizure clinics reduce hospitalizations, and AI's use in sleep neurology. When to withdraw life support for severe TBI, inflammatory markers score and stroke risk, application overload for neurology residency programs. When to withdraw life support for severe TBI, inflammatory markers score and stroke risk, application overload for neurology residency programs. Thu, 20 Jun 2024 03:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses a paper advising against prematurely withdrawing life support for severe TBI, data showing those with the highest composite score of inflammatory markers had a greater risk for stroke, original reporting stressing that residency programs and applicants need to adopt more strategic approaches to managing the overwhelming volume of applications.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.  

]]> In this week's podcast, Neurology Today's editor-in-chief discusses a paper advising against prematurely withdrawing life support for severe TBI, data showing those with the highest composite score of inflammatory markers had a greater risk for stroke, original reporting stressing that residency programs and applicants need to adopt more strategic approaches to managing the overwhelming volume of applications.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

]]> 04:45 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses a paper advising against prematurely withdrawing life support for severe TBI, data showing those with the highest composite score of inflammatory markers had a greater risk for stroke, original reporting stressing that residency programs and applicants need to adopt more strategic approaches to managing the overwhelming volume of applications. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.  In this week's podcast, Neurology Today's editor-in-chief discusses a paper advising against prematurely withdrawing life support for severe TBI, data showing those with the highest composite score of inflammatory markers had a greater risk for stroke, original reporting stressing that residency programs and applicants need to adopt more strategic approaches to managing the overwhelming volume of applications. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.   Code for ICH, new findings on Havana syndrome, distal symmetric polyneuropathy underdiagnosed in low income primary care clinics Code for ICH, new findings on Havana syndrome, distal symmetric polyneuropathy underdiagnosed in low income primary care clinics Thu, 06 Jun 2024 03:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses a push among neurocritical care experts to develop a code procedure for intracerebral hemorrhage, new findings showing people with Havana syndrome have functional neurologic disorder, and a study reporting distal symmetric polyneuropathy is more prevalent but less diagnosed in primary care clinics in low-income areas.  

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses a push among neurocritical care experts to develop a code procedure for intracerebral hemorrhage, new findings showing people with Havana syndrome have functional neurologic disorder, and a study reporting distal symmetric polyneuropathy is more prevalent but less diagnosed in primary care clinics in low-income areas.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

]]> 05:14 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses a push among neurocritical care experts to develop a code procedure for intracerebral hemorrhage, new findings showing people with Havana syndrome have functional neurologic disorder, and a study reporting distal symmetric polyneuropathy is more prevalent but less diagnosed in primary care clinics in low-income areas.   This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.In this week's podcast, Neurology Today's editor-in-chief discusses a push among neurocritical care experts to develop a code procedure for intracerebral hemorrhage, new findings showing people with Havana syndrome have functional neurologic disorder, and a study reporting distal symmetric polyneuropathy is more prevalent but less diagnosed in primary care clinics in low-income areas.   This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. Surgical removal of hematoma in ICH, disparities in neurodiagnosis for epilepsy, inequities among female neurology researchers Surgical removal of hematoma in ICH, disparities in neurodiagnosis for epilepsy, inequities among female neurology researchers Thu, 16 May 2024 03:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses a new study reporting better outcomes with surgical removal of hematoma in intracerebral hemorrhage, disparities in access to diagnosis and care for epilepsy, and the challenges that remain for women in neurology research.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses a new study reporting better outcomes with surgical removal of hematoma in intracerebral hemorrhage, disparities in access to diagnosis and care for epilepsy, and the challenges that remain for women in neurology research.

]]> 04:54 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses a new study reporting better outcomes with surgical removal of hematoma in intracerebral hemorrhage, disparities in access to diagnosis and care for epilepsy, and the challenges that remain for women in neurology research.In this week's podcast, Neurology Today's editor-in-chief discusses a new study reporting better outcomes with surgical removal of hematoma in intracerebral hemorrhage, disparities in access to diagnosis and care for epilepsy, and the challenges that remain for women in neurology research. Generative AI for personal statements, Match Day and neurology, AHS statement on CGRP-targeting therapies Generative AI for personal statements, Match Day and neurology, AHS statement on CGRP-targeting therapies Thu, 02 May 2024 03:00:00 +0000 Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new articles that discuss program directors' response to the use of generative AI for personal statements, the good news for neurology based on the 2024 Match Day, and the AHS statement on CGRP-targeting therapies as a game changer for migraine treatment.

]]> Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new articles that discuss program directors' response to the use of generative AI for personal statements, the good news for neurology based on the 2024 Match Day, and the AHS statement on CGRP-targeting therapies as a game changer for migraine treatment.

]]> 04:48 false full American Academy of Neurology Neurology TodayNeurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new articles that discuss program directors' response to the use of generative AI for personal statements, the good news for neurology based on the 2024 Match Day, and the AHS statement on CGRP-targeting therapies as a game changer for migraine treatment.Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new articles that discuss program directors' response to the use of generative AI for personal statements, the good news for neurology based on the 2024 Match Day, and the AHS statement on CGRP-targeting therapies as a game changer for migraine treatment. ME/CFS and long COVID; negative outcomes for ALS drug; donanemab ME/CFS and long COVID; negative outcomes for ALS drug; donanemab Thu, 18 Apr 2024 03:00:00 +0000 Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that explores an association between myalgic encephalomyelitis/chronic fatigue and long COVID; negative phase 3 findings on AMX0035 for ALS, and the pending approval of donanemab for Alzheimer's disease.

]]> Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that explores an association between myalgic encephalomyelitis/chronic fatigue and long COVID; negative phase 3 findings on AMX0035 for ALS, and the pending approval of donanemab for Alzheimer's disease.

]]> 04:31 false full American Academy of Neurology Neurology TodayNeurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that explores an association between myalgic encephalomyelitis/chronic fatigue and long COVID; negative phase 3 findings on AMX0035 for ALS, and the pending approval of donanemab for Alzheimer's disease.Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that explores an association between myalgic encephalomyelitis/chronic fatigue and long COVID; negative phase 3 findings on AMX0035 for ALS, and the pending approval of donanemab for Alzheimer's disease. BTK inhibitors for MS, lecanemab, neurologic adverse effects and COVID vaccine BTK inhibitors for MS, lecanemab, neurologic adverse effects and COVID vaccine Thu, 04 Apr 2024 03:00:00 +0000 Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that casts doubt on the future of BTK inhibitors for MS, an assessment of the cost-effectiveness of lecanemab, and findings that COVID vaccines are not significantly associated with adverse neurologic events.

]]> Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that casts doubt on the future of BTK inhibitors for MS, an assessment of the cost-effectiveness of lecanemab, and findings that COVID vaccines are not significantly associated with adverse neurologic events.

]]> 04:24 false full American Academy of Neurology Neurology TodayNeurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that casts doubt on the future of BTK inhibitors for MS, an assessment of the cost-effectiveness of lecanemab, and findings that COVID vaccines are not significantly associated with adverse neurologic events.Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that casts doubt on the future of BTK inhibitors for MS, an assessment of the cost-effectiveness of lecanemab, and findings that COVID vaccines are not significantly associated with adverse neurologic events. SARS-CoV-2 and dopamine neurons, valproate risks for men, neurologists on locum tenens SARS-CoV-2 and dopamine neurons, valproate risks for men, neurologists on locum tenens Thu, 21 Mar 2024 03:00:00 +0000 Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the impact of SARS-CoV2 on dopamine neurons, a European Medicines Agency warning about valproate risks for men, and neurologists on the pros and cons of working locum tenens.

]]> Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the impact of SARS-CoV2 on dopamine neurons, a European Medicines Agency warning about valproate risks for men, and neurologists on the pros and cons of working locum tenens.

]]> 04:38 false full American Academy of Neurology Neurology TodayNeurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the impact of SARS-CoV2 on dopamine neurons, a European Medicines Agency warning about valproate risks for men, and neurologists on the pros and cons of working locum tenens.Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the impact of SARS-CoV2 on dopamine neurons, a European Medicines Agency warning about valproate risks for men, and neurologists on the pros and cons of working locum tenens. AI and 911 stroke detection, iatrogenic Alzheimer's and human growth hormone, seizure dogs and refractory epilepsy AI and 911 stroke detection, iatrogenic Alzheimer's and human growth hormone, seizure dogs and refractory epilepsy Thu, 07 Mar 2024 04:00:00 +0000 Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the use of AI in EMS systems for stroke detection, the association between human growth hormone and iatrogenic Alzheimer's, and seizure dogs for refractory epilepsy.

]]> Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the use of AI in EMS systems for stroke detection, the association between human growth hormone and iatrogenic Alzheimer's, and seizure dogs for refractory epilepsy.

]]> 04:38 false full American Academy of Neurology Neurology TodayNeurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the use of AI in EMS systems for stroke detection, the association between human growth hormone and iatrogenic Alzheimer's, and seizure dogs for refractory epilepsy.Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the use of AI in EMS systems for stroke detection, the association between human growth hormone and iatrogenic Alzheimer's, and seizure dogs for refractory epilepsy. Biomarker for migraine; posterior cortical atrophy gene therapy for neuromuscular disorders Biomarker for migraine; posterior cortical atrophy gene therapy for neuromuscular disorders Mon, 12 Feb 2024 15:38:00 +0000 Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a new study showing retinal vascular perfusion as a migraine biomarker, clinical and pathophysiological correlates of posterior cortical atrophy, and advances in gene therapies for neuromuscular disorders.

]]> Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a new study showing retinal vascular perfusion as a migraine biomarker, clinical and pathophysiological correlates of posterior cortical atrophy, and advances in gene therapies for neuromuscular disorders.

]]> 04:30 false 24 4 full Joseph E. Safdieh, MD, FAAN Neurology TodayNeurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a new study showing retinal vascular perfusion as a migraine biomarker, clinical and pathophysiological correlates of posterior cortical atrophy, and advances in gene therapies for neuromuscular disorders.Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a new study showing retinal vascular perfusion as a migraine biomarker, clinical and pathophysiological correlates of posterior cortical atrophy, and advances in gene therapies for neuromuscular disorders. Cerebral amyloid angiopathy and nontraumatic subdural hemorrhage, AI for neurology boards, weight loss drugs and neurologic conditions Cerebral amyloid angiopathy and nontraumatic subdural hemorrhage, AI for neurology boards, weight loss drugs and neurologic conditions Thu, 25 Jan 2024 17:42:00 +0000 Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing the cerebral amyloid angiopathy as a risk factor for nontraumatic subdural hemorrhage, AI beats humans in neurology-like boards, and the impact of popular weight loss drugs on neurologic conditions.

]]> Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing the cerebral amyloid angiopathy as a risk factor for nontraumatic subdural hemorrhage, AI beats humans in neurology-like boards, and the impact of popular weight loss drugs on neurologic conditions.

]]> 04:39 false full Neurology TodayNeurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing the cerebral amyloid angiopathy as a risk factor for nontraumatic subdural hemorrhage, AI beats humans in neurology-like boards, and the impact of popular weight loss drugs on neurologic conditions.Neurology TodayNeurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing the cerebral amyloid angiopathy as a risk factor for nontraumatic subdural hemorrhage, AI beats humans in neurology-like boards, and the impact of popular weight loss drugs on neurologic conditions. Rising incidence of Creutzfeldt-Jakob disease, therapy for prodromal migraine, neurotrauma of blast injury Rising incidence of Creutzfeldt-Jakob disease, therapy for prodromal migraine, neurotrauma of blast injury Tue, 16 Jan 2024 15:25:00 +0000 04:18 false full Joseph E. Safdieh, MD, FAAN Neurology TodayNeurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing the rising incidence of Creutzfeldt-Jakob disease, an effective therapy for prodromal migaine, and neuroinflammation in military personnel exposed to blast injury.Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing the rising incidence of Creutzfeldt-Jakob disease, an effective therapy for prodromal migaine, and neuroinflammation in military personnel exposed to blast injury. DBS and cognition in severe TBI, in utero exposure to antiseizure drugs, best advances of 2023 DBS and cognition in severe TBI, in utero exposure to antiseizure drugs, best advances of 2023 Tue, 02 Jan 2024 05:00:02 +0000 Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on the impact of deep brain stimulation on cognition in severe traumatic brain injury and how adaptive functioning is impacted in children exposed to antiseizure drugs in utero, and the editorial board's picks for the best advances of 2023.

]]> Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on the impact of deep brain stimulation on cognition in severe traumatic brain injury and how adaptive functioning is impacted in children exposed to antiseizure drugs in utero, and the editorial board's picks for the best advances of 2023.

]]> 04:08 false full Joseph E. Safdieh, MD, FAAN Neurology TodayNeurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on the impact of deep brain stimulation on cognition in severe traumatic brain injury and how adaptive functioning is impacted in children exposed to antiseizure drugs in utero, and the editorial board's picks for the best advances of 2023.Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on the impact of deep brain stimulation on cognition in severe traumatic brain injury and how adaptive functioning is impacted in children exposed to antiseizure drugs in utero, and the editorial board's picks for the best advances of 2023. Parkinson's and suicide risk; biomarkers and underrepresentation in Alzheimer's trials, immune system changes in ALS and Parkinson's. Parkinson's and suicide risk; biomarkers and underrepresentation in Alzheimer's trials, immune system changes in ALS and Parkinson's. Thu, 21 Dec 2023 05:00:00 +0000 Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing double the suicide risk among Parkinson's patients; underrepresentation of non-White people in Alzheimer's trial related to biomarker eligibility; early immune systems changes may play early role in ALS and Parkinson's.

]]> Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing double the suicide risk among Parkinson's patients; underrepresentation of non-White people in Alzheimer's trial related to biomarker eligibility; early immune systems changes may play early role in ALS and Parkinson's.

]]> 04:36 false full American Academy of Neurology Neurology TodayNeurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing double the suicide risk among Parkinson's patients; underrepresentation of non-White people in Alzheimer's trial related to biomarker eligibility; early immune systems changes may play early role in ALS and Parkinson's.Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing double the suicide risk among Parkinson's patients; underrepresentation of non-White people in Alzheimer's trial related to biomarker eligibility; early immune systems changes may play early role in ALS and Parkinson's. Serotonin and long COVID, Afib detected 3 years after stroke, Medicare on PET amyloid scans Serotonin and long COVID, Afib detected 3 years after stroke, Medicare on PET amyloid scans Thu, 07 Dec 2023 05:00:00 +0000 Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing serotonin depletion associated with long COVID; implantable cardiac monitors detect Afib 3 years post-stroke; and what Medicare's decision to cover PET amyloid scans means for neurologists.

]]> Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing serotonin depletion associated with long COVID; implantable cardiac monitors detect Afib 3 years post-stroke; and what Medicare's decision to cover PET amyloid scans means for neurologists.

]]> 04:43 false full American Academy of Neurology Neurology TodayNeurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing serotonin depletion associated with long COVID; implantable cardiac monitors detect Afib 3 years post-stroke; and what Medicare's decision to cover PET amyloid scans means for neurologists.Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing serotonin depletion associated with long COVID; implantable cardiac monitors detect Afib 3 years post-stroke; and what Medicare's decision to cover PET amyloid scans means for neurologists. A promising drug for refractory epilepsy; adverse childhood events and headache disorders; pathological engulfment by microglia in dementia. A promising drug for refractory epilepsy; adverse childhood events and headache disorders; pathological engulfment by microglia in dementia. Thu, 16 Nov 2023 05:00:00 +0000 Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on a promising potassium channel opener for refractory epilepsy; the impact of adverse childhood events in headache disorders; and excessive engulfment by microglia/astroctyes in dementia.

]]> Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on a promising potassium channel opener for refractory epilepsy; the impact of adverse childhood events in headache disorders; and excessive engulfment by microglia/astroctyes in dementia.

]]> 04:49 false full American Academy of Neurology Neurology TodayNeurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on a promising potassium channel opener for refractory epilepsy; the impact of adverse childhood events in headache disorders; and excessive engulfment by microglia/astroctyes in dementia.Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on a promising potassium channel opener for refractory epilepsy; the impact of adverse childhood events in headache disorders; and excessive engulfment by microglia/astroctyes in dementia. Blood transfusions and spontaneous intracerebral hemorrhages, long distance travel to neurologists, biomarkers for Parkinson's disease Blood transfusions and spontaneous intracerebral hemorrhages, long distance travel to neurologists, biomarkers for Parkinson's disease Thu, 02 Nov 2023 04:00:00 +0000 Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on the risk of spontaneous intracerebral hemorrhages after blood transfusions; the burden of long distance travel to see neurologists; and two promising biomarkers for early diagnosis of Parkinson's disease.

]]> Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on the risk of spontaneous intracerebral hemorrhages after blood transfusions; the burden of long distance travel to see neurologists; and two promising biomarkers for early diagnosis of Parkinson's disease.

]]> 04:43 false full American Academy of Neurology Neurology TodayNeurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on the risk of spontaneous intracerebral hemorrhages after blood transfusions; the burden of long distance travel to see neurologists; and two promising biomarkers for early diagnosis of Parkinson's disease.Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on the risk of spontaneous intracerebral hemorrhages after blood transfusions; the burden of long distance travel to see neurologists; and two promising biomarkers for early diagnosis of Parkinson's disease. Blood pressure and endovascular therapy, cutbacks in neurology CME, blood test for Alzheimer's Blood pressure and endovascular therapy, cutbacks in neurology CME, blood test for Alzheimer's Thu, 19 Oct 2023 04:00:00 +0000 Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on blood pressure targets for stroke after endovascular therapy, changing policies on CME, and a direct-to-consumer blood test for Alzheimer's disease.

]]> Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on blood pressure targets for stroke after endovascular therapy, changing policies on CME, and a direct-to-consumer blood test for Alzheimer's disease.

]]> 04:47 false full American Academy of Neurology Neurology TodayNeurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on blood pressure targets for stroke after endovascular therapy, changing policies on CME, and a direct-to-consumer blood test for Alzheimer's disease.Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on blood pressure targets for stroke after endovascular therapy, changing policies on CME, and a direct-to-consumer blood test for Alzheimer's disease. Football and Parkinson's, deep brain stimulation for stroke recovery, neuroprostheses for anarthric patients Football and Parkinson's, deep brain stimulation for stroke recovery, neuroprostheses for anarthric patients Thu, 05 Oct 2023 04:00:00 +0000 Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on football and the risk for Parkinson's disease, the potential of deep brain stimulation for recovery from stroke, and neuroprostheses for patients with anarthria.

]]> Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on football and the risk for Parkinson's disease, the potential of deep brain stimulation for recovery from stroke, and neuroprostheses for patients with anarthria.

]]> 04:47 false full American Academy of Neurology Neurology TodayNeurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on football and the risk for Parkinson's disease, the potential of deep brain stimulation for recovery from stroke, and neuroprostheses for patients with anarthria.Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on football and the risk for Parkinson's disease, the potential of deep brain stimulation for recovery from stroke, and neuroprostheses for patients with anarthria. Medicare coverage of carotid stenting, disparities in vulnerable neuro-oncology patients, optical EMG for neuromuscular disorders. Medicare coverage of carotid stenting, disparities in vulnerable neuro-oncology patients, optical EMG for neuromuscular disorders. Thu, 21 Sep 2023 09:00:00 +0000 Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses the Medicare's proposed coverage of carotid stenting in asymptomatic patients,neuro-oncologists' perspectives on a federal initiative to target persistent poverty in vulnerable patients, and the technological promise of a new optical EMG for neuromuscular disorders.

]]> Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses the Medicare's proposed coverage of carotid stenting in asymptomatic patients,neuro-oncologists' perspectives on a federal initiative to target persistent poverty in vulnerable patients, and the technological promise of a new optical EMG for neuromuscular disorders.

]]> 05:12 false full American Academy of Neurology Neurology TodayNeurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses the Medicare's proposed coverage of carotid stenting in asymptomatic patients,neuro-oncologists' perspectives on a federal initiative to target persistent poverty in vulnerable patients, and the technological promise of a new optical EMG for neuromuscular disorders.Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses the Medicare's proposed coverage of carotid stenting in asymptomatic patients,neuro-oncologists' perspectives on a federal initiative to target persistent poverty in vulnerable patients, and the technological promise of a new optical EMG for neuromuscular disorders. Endovascular treatment and intracranial tumors; guideline on IVIG use for neuromuscular disorders, pros and cons of donanemab. Endovascular treatment and intracranial tumors; guideline on IVIG use for neuromuscular disorders, pros and cons of donanemab. Thu, 07 Sep 2023 04:00:00 +0000 Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses research that assesses the safety of endovascular treatment post-stroke for people with intracranial tumors, the AANEM guideline on IVIG use for neuromuscular disorders, and the latest data on donanemab.

]]> Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses research that assesses the safety of endovascular treatment post-stroke for people with intracranial tumors, the AANEM guideline on IVIG use for neuromuscular disorders, and the latest data on donanemab.

]]> 05:27 false full American Academy of Neurology Neurology TodayNeurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses research that assesses the safety of endovascular treatment post-stroke for people with intracranial tumors, the AANEM guideline on IVIG use for neuromuscular disorders, and the latest data on donanemab.Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses research that assesses the safety of endovascular treatment post-stroke for people with intracranial tumors, the AANEM guideline on IVIG use for neuromuscular disorders, and the latest data on donanemab. Oral health and cognitive decline; managing first-ever sleep seizures; growth of concierge neurology. Oral health and cognitive decline; managing first-ever sleep seizures; growth of concierge neurology. Thu, 17 Aug 2023 04:00:00 +0000 Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses studies that associate poor oral health and risk for cognitive decline and how to manage first-ever sleep seizures that recur as well as the growth of concierge neurology.

]]> Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses studies that associate poor oral health and risk for cognitive decline and how to manage first-ever sleep seizures that recur as well as the growth of concierge neurology.

]]> 04:56 false full American Academy of Neurology Neurology TodayNeurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses studies that associate poor oral health and risk for cognitive decline and how to manage first-ever sleep seizures that recur as well as the growth of concierge neurology.Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses studies that associate poor oral health and risk for cognitive decline and how to manage first-ever sleep seizures that recur as well as the growth of concierge neurology. Gene variants and MS severity, AI and EEG reads, neuroprotective agent for ischemic stroke Gene variants and MS severity, AI and EEG reads, neuroprotective agent for ischemic stroke Thu, 03 Aug 2023 04:00:00 +0000 Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses studies that identify gene variants associated with MS severity/progression, an AI program that read EEGs accurately, and butylphthalide as a promising neuroprotective agent for ischemic stroke.

]]> Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses studies that identify gene variants associated with MS severity/progression, an AI program that read EEGs accurately, and butylphthalide as a promising neuroprotective agent for ischemic stroke.

]]> 05:43 false full American Academy of Neurology Neurology TodayNeurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses studies that identify gene variants associated with MS severity/progression, an AI program that read EEGs accurately, and butylphthalide as a promising neuroprotective agent for ischemic stroke.Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses studies that identify gene variants associated with MS severity/progression, an AI program that read EEGs accurately, and butylphthalide as a promising neuroprotective agent for ischemic stroke. Antigen tolerance in mouse MS model, epileptiform activity and ICU outcomes, agent slows gliomas. Antigen tolerance in mouse MS model, epileptiform activity and ICU outcomes, agent slows gliomas. Thu, 20 Jul 2023 04:00:00 +0000 Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a novel therapeutic approach that induced antigen tolerance in an MS mouse model, the association between epileptiform activity and ICU outcomes, and an agent, vorasidenib, that slows low-grade gliomas.

]]> Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a novel therapeutic approach that induced antigen tolerance in an MS mouse model, the association between epileptiform activity and ICU outcomes, and an agent, vorasidenib, that slows low-grade gliomas.

]]> 05:12 false full American Academy of Neurology Neurology TodayNeurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a novel therapeutic approach that induced antigen tolerance in an MS mouse model, the association between epileptiform activity and ICU outcomes, and an agent, vorasidenib, that slows low-grade gliomas.Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a novel therapeutic approach that induced antigen tolerance in an MS mouse model, the association between epileptiform activity and ICU outcomes, and an agent, vorasidenib, that slows low-grade gliomas. Gout and risk of neurodegenereative diseases, Tenecteplase compared with warfarin, cognitive decline after heart attack Gout and risk of neurodegenereative diseases, Tenecteplase compared with warfarin, cognitive decline after heart attack Thu, 06 Jul 2023 04:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses the association between gout and neurodegenerative diseases, tenecrteplase vs.warfarin for acute stroke, expedited cognitive decline after a heart attack.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses the association between gout and neurodegenerative diseases, tenecrteplase vs.warfarin for acute stroke, expedited cognitive decline after a heart attack.

]]> 05:27 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses the association between gout and neurodegenerative diseases, tenecrteplase vs.warfarin for acute stroke, expedited cognitive decline after a heart attack.In this week's podcast, Neurology Today's editor-in-chief discusses the association between gout and neurodegenerative diseases, tenecrteplase vs.warfarin for acute stroke, expedited cognitive decline after a heart attack. Antipsychotic for dementia-related agitation, contaminated water at Camp Lejeune associated with elevated risk for Parkinson's, gene variant confers resilience against autosomal dominant Alzheimer's. Antipsychotic for dementia-related agitation, contaminated water at Camp Lejeune associated with elevated risk for Parkinson's, gene variant confers resilience against autosomal dominant Alzheimer's. Thu, 15 Jun 2023 04:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses the FDA approval of an antipsychotic for agitation in dementia, elevated risk for Parkinson's in Camp Lejeune Marines exposed to contaminated water, a gene variant delays the onset of symptoms in man with autosomal dominant Alzheimer's.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses the FDA approval of an antipsychotic for agitation in dementia, elevated risk for Parkinson's in Camp Lejeune Marines exposed to contaminated water, a gene variant delays the onset of symptoms in man with autosomal dominant Alzheimer's.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

]]> 05:29 false 2 full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses the FDA approval of an antipsychotic for agitation in dementia, elevated risk for Parkinson's in Camp Lejeune Marines exposed to contaminated water, a gene variant delays the onset of symptoms in man with autosomal dominant Alzheimer's. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.In this week's podcast, Neurology Today's editor-in-chief discusses the FDA approval of an antipsychotic for agitation in dementia, elevated risk for Parkinson's in Camp Lejeune Marines exposed to contaminated water, a gene variant delays the onset of symptoms in man with autosomal dominant Alzheimer's. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. OnabotulinumtoxinA for pregnant women with migraine, adderrall shortage, AI for epilepsy OnabotulinumtoxinA for pregnant women with migraine, adderrall shortage, AI for epilepsy Thu, 01 Jun 2023 04:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses a study on the safety of omnabotuliumtoxinA on pregnant women with migraine, the impact of the Adderall shortage on patients with ADHD and narcolepsy, and the state of AI for epilepsy. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses a study on the safety of omnabotuliumtoxinA on pregnant women with migraine, the impact of the Adderall shortage on patients with ADHD and narcolepsy, and the state of AI for epilepsy. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

]]> 05:12 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses a study on the safety of omnabotuliumtoxinA on pregnant women with migraine, the impact of the Adderall shortage on patients with ADHD and narcolepsy, and the state of AI for epilepsy. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.In this week's podcast, Neurology Today's editor-in-chief discusses a study on the safety of omnabotuliumtoxinA on pregnant women with migraine, the impact of the Adderall shortage on patients with ADHD and narcolepsy, and the state of AI for epilepsy. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. Assay detects Parkinson's before symptom onset; life stressors in pregnant women with epilepsy; role of inflammation in NORSE Assay detects Parkinson's before symptom onset; life stressors in pregnant women with epilepsy; role of inflammation in NORSE Thu, 18 May 2023 04:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses a new study reporting a gene assay detected Parkinson's before symptoms onset, life stressors greatly impact women with epilepsy during pregnancy; the role of inflammation in new-onset refractory status epilepticus.

 This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses a new study reporting a gene assay detected Parkinson's before symptoms onset, life stressors greatly impact women with epilepsy during pregnancy; the role of inflammation in new-onset refractory status epilepticus.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

]]> 05:23 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses a new study reporting a gene assay detected Parkinson's before symptoms onset, life stressors greatly impact women with epilepsy during pregnancy; the role of inflammation in new-onset refractory status epilepticus.  This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.In this week's podcast, Neurology Today's editor-in-chief discusses a new study reporting a gene assay detected Parkinson's before symptoms onset, life stressors greatly impact women with epilepsy during pregnancy; the role of inflammation in new-onset refractory status epilepticus.  This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. Anticoagulants for patients with dementia and Afib, tau levels in women taking hormone replace therapy, neurohumanities programs for neurology residents. Anticoagulants for patients with dementia and Afib, tau levels in women taking hormone replace therapy, neurohumanities programs for neurology residents. Thu, 04 May 2023 04:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses a new study finding anticoagulants are safe for patients with atrial fibrillation and dementia, women on hormone replacement therapy had higher tau levels, and neurology residents are participants in humanities programs to foster wellness.  

]]> In this week's podcast, Neurology Today's editor-in-chief discusses a new study finding anticoagulants are safe for patients with atrial fibrillation and dementia, women on hormone replacement therapy had higher tau levels, and neurology residents are participants in humanities programs to foster wellness.

]]> 05:56 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses a new study finding anticoagulants are safe for patients with atrial fibrillation and dementia, women on hormone replacement therapy had higher tau levels, and neurology residents are participants in humanities programs to foster wellness.  In this week's podcast, Neurology Today's editor-in-chief discusses a new study finding anticoagulants are safe for patients with atrial fibrillation and dementia, women on hormone replacement therapy had higher tau levels, and neurology residents are participants in humanities programs to foster wellness.   Fertility treatments for women with MS, stroke systems of care, ravalizumab for NMOSD Fertility treatments for women with MS, stroke systems of care, ravalizumab for NMOSD Thu, 20 Apr 2023 04:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses a new study finding fertility treatments did not lead to MS relapses for women, a AHA consensus statement that finds stroke systems need improvement, and ravalizumab at less frequent doses was effective for neuromyelitis optica spectrum disorder.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses a new study finding fertility treatments did not lead to MS relapses for women, a AHA consensus statement that finds stroke systems need improvement, and ravalizumab at less frequent doses was effective for neuromyelitis optica spectrum disorder.

]]> 05:59 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses a new study finding fertility treatments did not lead to MS relapses for women, a AHA consensus statement that finds stroke systems need improvement, and ravalizumab at less frequent doses was effective for neuromyelitis optica spectrum disorder.In this week's podcast, Neurology Today's editor-in-chief discusses a new study finding fertility treatments did not lead to MS relapses for women, a AHA consensus statement that finds stroke systems need improvement, and ravalizumab at less frequent doses was effective for neuromyelitis optica spectrum disorder. Intranasal CGRP for migraine, ultrasound ablation for Parkinson's disease, novel therapeutic pathway for Duchenne muscular atrophy. Intranasal CGRP for migraine, ultrasound ablation for Parkinson's disease, novel therapeutic pathway for Duchenne muscular atrophy. Thu, 06 Apr 2023 04:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses the newly approved zavegepant for migraine, the potential/caveats of ultrasound ablation for Parkinson's disease, the transational potential of a new therapeutic target for Duchenne muscular atrophy.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses the newly approved zavegepant for migraine, the potential/caveats of ultrasound ablation for Parkinson's disease, the transational potential of a new therapeutic target for Duchenne muscular atrophy.

]]> 06:06 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses the newly approved zavegepant for migraine, the potential/caveats of ultrasound ablation for Parkinson's disease, the transational potential of a new therapeutic target for Duchenne muscular atrophy.In this week's podcast, Neurology Today's editor-in-chief discusses the newly approved zavegepant for migraine, the potential/caveats of ultrasound ablation for Parkinson's disease, the transational potential of a new therapeutic target for Duchenne muscular atrophy. Antipsychotics and dementia risk; biomarkers for lecanemab eligibility; trial of difelikefalin for neurogenic itch in notaliga paresthetica. Antipsychotics and dementia risk; biomarkers for lecanemab eligibility; trial of difelikefalin for neurogenic itch in notaliga paresthetica. Thu, 16 Mar 2023 04:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses the increased use of antipsychotics during the pandemic and an associated greater risk for dementia, determining the best biomarkers when considering lecanemab for Alzheimer's, and a novel approach for managing uncomfortable neuropathic symptoms.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses the increased use of antipsychotics during the pandemic and an associated greater risk for dementia, determining the best biomarkers when considering lecanemab for Alzheimer's, and a novel approach for managing uncomfortable neuropathic symptoms.

]]> 06:07 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses the increased use of antipsychotics during the pandemic and an associated greater risk for dementia, determining the best biomarkers when considering lecanemab for Alzheimer's, and a novel approach for managing uncomfortable neuropathic symptoms.In this week's podcast, Neurology Today's editor-in-chief discusses the increased use of antipsychotics during the pandemic and an associated greater risk for dementia, determining the best biomarkers when considering lecanemab for Alzheimer's, and a novel approach for managing uncomfortable neuropathic symptoms. Pregnancy-associated stroke outcomes; a robotic device for shoulder movement in ALS; non-invasive neurostimulation for refractory seizures. Pregnancy-associated stroke outcomes; a robotic device for shoulder movement in ALS; non-invasive neurostimulation for refractory seizures. Thu, 02 Mar 2023 05:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses long-term adverse outcomes from pregnancy-associated stroke, a robotic device to assist shoulder movement in ALS, and the promise of neurostimulation for refractory seizures in the ICU.  

]]> In this week's podcast, Neurology Today's editor-in-chief discusses long-term adverse outcomes from pregnancy-associated stroke, a robotic device to assist shoulder movement in ALS, and the promise of neurostimulation for refractory seizures in the ICU.

]]> 05:55 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses long-term adverse outcomes from pregnancy-associated stroke, a robotic device to assist shoulder movement in ALS, and the promise of neurostimulation for refractory seizures in the ICU.  In this week's podcast, Neurology Today's editor-in-chief discusses long-term adverse outcomes from pregnancy-associated stroke, a robotic device to assist shoulder movement in ALS, and the promise of neurostimulation for refractory seizures in the ICU.   Acute infections and increased risk for dementia, alternatives to CPAP for sleep apnea; the legacy of Dr. Ralph Sacco. Acute infections and increased risk for dementia, alternatives to CPAP for sleep apnea; the legacy of Dr. Ralph Sacco. Thu, 16 Feb 2023 05:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses the associated risk between acute infections and dementia; alternative therapies to CPAP for sleep apnea; and Dr. Ralph Sacco's impact on the field.  

]]> In this week's podcast, Neurology Today's editor-in-chief discusses the associated risk between acute infections and dementia; alternative therapies to CPAP for sleep apnea; and Dr. Ralph Sacco's impact on the field.

]]> 05:30 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses the associated risk between acute infections and dementia; alternative therapies to CPAP for sleep apnea; and Dr. Ralph Sacco's impact on the field.  In this week's podcast, Neurology Today's editor-in-chief discusses the associated risk between acute infections and dementia; alternative therapies to CPAP for sleep apnea; and Dr. Ralph Sacco's impact on the field.   IV thrombolysis for large vessel occlusion; impact of mindfulness, exercise on cognition;new brain layer in subarachnoid space. IV thrombolysis for large vessel occlusion; impact of mindfulness, exercise on cognition;new brain layer in subarachnoid space. Thu, 02 Feb 2023 05:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses the report on outcomes of IV thrombolysis for large vessel occlusions; the discovery of a new brain layer in the subarachnoid space; and the impact of mindfulness and exercise on cognition.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses the report on outcomes of IV thrombolysis for large vessel occlusions; the discovery of a new brain layer in the subarachnoid space; and the impact of mindfulness and exercise on cognition.

]]> 05:31 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses the report on outcomes of IV thrombolysis for large vessel occlusions; the discovery of a new brain layer in the subarachnoid space; and the impact of mindfulness and exercise on cognition.In this week's podcast, Neurology Today's editor-in-chief discusses the report on outcomes of IV thrombolysis for large vessel occlusions; the discovery of a new brain layer in the subarachnoid space; and the impact of mindfulness and exercise on cognition. Best advances of 2022, misdiagnosed autoimmune encephalitis, inflation his neurology private practice Best advances of 2022, misdiagnosed autoimmune encephalitis, inflation his neurology private practice Thu, 19 Jan 2023 05:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses the report on misdiagnosis of autoimmune encephalitis, inflationary times for neurologists in private practice, and the editorial board picks for best advances in 2022.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses the report on misdiagnosis of autoimmune encephalitis, inflationary times for neurologists in private practice, and the editorial board picks for best advances in 2022.

]]> 05:50 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses the report on misdiagnosis of autoimmune encephalitis, inflationary times for neurologists in private practice, and the editorial board picks for best advances in 2022.In this week's podcast, Neurology Today's editor-in-chief discusses the report on misdiagnosis of autoimmune encephalitis, inflationary times for neurologists in private practice, and the editorial board picks for best advances in 2022. Spinal cord stimulation for chronic pain, disparities in brain age by race/ethnicity, careers in teleneurology Spinal cord stimulation for chronic pain, disparities in brain age by race/ethnicity, careers in teleneurology Wed, 04 Jan 2023 05:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses a comparison of spinal cord stimulation with medical management for chronic pain, earlier brain aging in Black people, and the pros/cons of working for teleneurology companies.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses a comparison of spinal cord stimulation with medical management for chronic pain, earlier brain aging in Black people, and the pros/cons of working for teleneurology companies.

]]> 05:04 false full Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses a comparison of spinal cord stimulation with medical management for chronic pain, earlier brain aging in Black people, and the pros/cons of working for teleneurology companies.Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses a comparison of spinal cord stimulation with medical management for chronic pain, earlier brain aging in Black people, and the pros/cons of working for teleneurology companies. Rituximab for MS, food security and cognition, in utero treatment for Pompe disease Rituximab for MS, food security and cognition, in utero treatment for Pompe disease Thu, 15 Dec 2022 10:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses why MS specialists advocate for rituximab for MS, how food security may relate to cognition, and a novel in utero therapy for Pompe diseasea.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses why MS specialists advocate for rituximab for MS, how food security may relate to cognition, and a novel in utero therapy for Pompe diseasea.

]]> 05:56 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses why MS specialists advocate for rituximab for MS, how food security may relate to cognition, and a novel in utero therapy for Pompe diseasea.In this week's podcast, Neurology Today's editor-in-chief discusses why MS specialists advocate for rituximab for MS, how food security may relate to cognition, and a novel in utero therapy for Pompe diseasea. Modifiable risk factors for monogenic stroke, health care systems prepare for wave of new Alzheimer's therapies, criteria for selecting neurology residents Modifiable risk factors for monogenic stroke, health care systems prepare for wave of new Alzheimer's therapies, criteria for selecting neurology residents Thu, 01 Dec 2022 05:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses modifiable risk factors for monogenic stroke, what health care systems need to do to prepare for new Alzheimer's therapies, and criteria program directors apply in selecting neurology residents.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses modifiable risk factors for monogenic stroke, what health care systems need to do to prepare for new Alzheimer's therapies, and criteria program directors apply in selecting neurology residents.

]]> 05:15 false full Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses modifiable risk factors for monogenic stroke, what health care systems need to do to prepare for new Alzheimer's therapies, and criteria program directors apply in selecting neurology residents.Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses modifiable risk factors for monogenic stroke, what health care systems need to do to prepare for new Alzheimer's therapies, and criteria program directors apply in selecting neurology residents. Revascular therapies for stroke patients with COVID, dementia and suicide risk, hyperbaric oxygen therapy for concussion in children. Revascular therapies for stroke patients with COVID, dementia and suicide risk, hyperbaric oxygen therapy for concussion in children. Thu, 17 Nov 2022 05:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses data suggesting revascular therapies are safe for patients with stroke and COVID, dementia is associated with increased suicide risk, and the potential of hyperbaric oxygen therapy for children with concussion.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses data suggesting revascular therapies are safe for patients with stroke and COVID, dementia is associated with increased suicide risk, and the potential of hyperbaric oxygen therapy for children with concussion.

]]> 05:13 false full Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses data suggesting revascular therapies are safe for patients with stroke and COVID, dementia is associated with increased suicide risk, and the potential of hyperbaric oxygen therapy for children with concussion.Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses data suggesting revascular therapies are safe for patients with stroke and COVID, dementia is associated with increased suicide risk, and the potential of hyperbaric oxygen therapy for children with concussion. Allergies and dementia risk, folic acid and risk of cancer in children of women with epilepsy, climate change and neurologic disorders. Allergies and dementia risk, folic acid and risk of cancer in children of women with epilepsy, climate change and neurologic disorders. Thu, 03 Nov 2022 04:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses data suggesting allergic disease is associated with an increased risk of dementia, an increased risk of cancer in children born to women with epilepsy who took high-dose folic acid in pregnancy, and the impact of climate change on people with neurologic disorders.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses data suggesting allergic disease is associated with an increased risk of dementia, an increased risk of cancer in children born to women with epilepsy who took high-dose folic acid in pregnancy, and the impact of climate change on people with neurologic disorders.

]]> 05:47 false full Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses data suggesting allergic disease is associated with an increased risk of dementia, an increased risk of cancer in children born to women with epilepsy who took high-dose folic acid in pregnancy, and the impact of climate change on people with neurologic disorders.Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses data suggesting allergic disease is associated with an increased risk of dementia, an increased risk of cancer in children born to women with epilepsy who took high-dose folic acid in pregnancy, and the impact of climate change on people with neurologic disorders. Vamorolone for DMD, aquaporin protein and amyloid clearance, monkey pox-associated neurologic events. Vamorolone for DMD, aquaporin protein and amyloid clearance, monkey pox-associated neurologic events. Thu, 20 Oct 2022 04:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses data suggesting vamorolone as an alternative to corticosteroids for Duchenne muscular dystrophy, how an aquaporin protein promotes amyloid clearance, and neurologic events associated with monkeypox virus.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses data suggesting vamorolone as an alternative to corticosteroids for Duchenne muscular dystrophy, how an aquaporin protein promotes amyloid clearance, and neurologic events associated with monkeypox virus.

]]> 05:28 false full Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses data suggesting vamorolone as an alternative to corticosteroids for Duchenne muscular dystrophy, how an aquaporin protein promotes amyloid clearance, and neurologic events associated with monkeypox virus.Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses data suggesting vamorolone as an alternative to corticosteroids for Duchenne muscular dystrophy, how an aquaporin protein promotes amyloid clearance, and neurologic events associated with monkeypox virus. Chronic kidney disease and risk for intracerebral hemorrhage, gonadotropic replacement and cogntion in Down syndrome, how to distinguish polio from other viruses Chronic kidney disease and risk for intracerebral hemorrhage, gonadotropic replacement and cogntion in Down syndrome, how to distinguish polio from other viruses Thu, 06 Oct 2022 04:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses new findings on chronic kidney disease and risk for intracerebral hemorrhage, the potential of  gonadotropic replacement for improving cognition in Down syndrome, and distinguishing polio from acute flaccid myelitis and other viruses.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses new findings on chronic kidney disease and risk for intracerebral hemorrhage, the potential of gonadotropic replacement for improving cognition in Down syndrome, and distinguishing polio from acute flaccid myelitis and other viruses.

]]> 05:14 false full Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses new findings on chronic kidney disease and risk for intracerebral hemorrhage, the potential of  gonadotropic replacement for improving cognition in Down syndrome, and distinguishing polio from acute flaccid myelitis and other viruses.Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses new findings on chronic kidney disease and risk for intracerebral hemorrhage, the potential of  gonadotropic replacement for improving cognition in Down syndrome, and distinguishing polio from acute flaccid myelitis and other viruses. Decompression and Chiari malformation, atrial cardiopathy and dementia risk, 3D printing the brain. Decompression and Chiari malformation, atrial cardiopathy and dementia risk, 3D printing the brain. Thu, 15 Sep 2022 04:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses new findings on decompression for Chiari malformation, the association of atrial cardiopathy with dementia, and a neurology resident's 3D printing of brain model.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses new findings on decompression for Chiari malformation, the association of atrial cardiopathy with dementia, and a neurology resident's 3D printing of brain model.

]]> 04:19 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses new findings on decompression for Chiari malformation, the association of atrial cardiopathy with dementia, and a neurology resident's 3D printing of brain model.In this week's podcast, Neurology Today's editor-in-chief discusses new findings on decompression for Chiari malformation, the association of atrial cardiopathy with dementia, and a neurology resident's 3D printing of brain model. Processed foods and dementia risk, therapies for vertigo, impostor syndrome Processed foods and dementia risk, therapies for vertigo, impostor syndrome Thu, 01 Sep 2022 09:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses the increased associated risk between processed foods and dementia risk, antihistamines vs. benzodiazepines for vertigo, and impostor syndrome in neurology. 

]]> In this week's podcast, Neurology Today's editor-in-chief discusses the increased associated risk between processed foods and dementia risk, antihistamines vs. benzodiazepines for vertigo, and impostor syndrome in neurology.

]]> 04:48 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses the increased associated risk between processed foods and dementia risk, antihistamines vs. benzodiazepines for vertigo, and impostor syndrome in neurology. In this week's podcast, Neurology Today's editor-in-chief discusses the increased associated risk between processed foods and dementia risk, antihistamines vs. benzodiazepines for vertigo, and impostor syndrome in neurology.  Spinal cord stimulation for diabetic neuropathy, Roe v. Wade reversal, diversifying the neurology pipeline. Spinal cord stimulation for diabetic neuropathy, Roe v. Wade reversal, diversifying the neurology pipeline. Thu, 18 Aug 2022 09:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses spinal cord stimulation for painful diabetic neuropathy, the Roe v. Wade reversal and neurology, and initiatives to diversify the neurology pipeline.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses spinal cord stimulation for painful diabetic neuropathy, the Roe v. Wade reversal and neurology, and initiatives to diversify the neurology pipeline.

]]> 04:46 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses spinal cord stimulation for painful diabetic neuropathy, the Roe v. Wade reversal and neurology, and initiatives to diversify the neurology pipeline.In this week's podcast, Neurology Today's editor-in-chief discusses spinal cord stimulation for painful diabetic neuropathy, the Roe v. Wade reversal and neurology, and initiatives to diversify the neurology pipeline. Functional neurologic disorder, newborn screening for SMA, when to leave job Functional neurologic disorder, newborn screening for SMA, when to leave job Thu, 04 Aug 2022 09:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses new thinking about functional neurologic disorders, the benefits of screening newborns for spinal muscular atrophy, and career advice on when to leave a job in neurology.  

]]> In this week's podcast, Neurology Today's editor-in-chief discusses new thinking about functional neurologic disorders, the benefits of screening newborns for spinal muscular atrophy, and career advice on when to leave a job in neurology.

]]> 04:35 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses new thinking about functional neurologic disorders, the benefits of screening newborns for spinal muscular atrophy, and career advice on when to leave a job in neurology.  In this week's podcast, Neurology Today's editor-in-chief discusses new thinking about functional neurologic disorders, the benefits of screening newborns for spinal muscular atrophy, and career advice on when to leave a job in neurology.   Functional neurologic disorder, newborn screening for SMA, when to leave job Functional neurologic disorder, newborn screening for SMA, when to leave job Thu, 04 Aug 2022 09:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses new thinking about functional neurologic disorders, the benefits of screening newborns for spinal muscular atrophy, and career advice on when to leave a job in neurology.  

]]> In this week's podcast, Neurology Today's editor-in-chief discusses new thinking about functional neurologic disorders, the benefits of screening newborns for spinal muscular atrophy, and career advice on when to leave a job in neurology.

]]> 04:35 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses new thinking about functional neurologic disorders, the benefits of screening newborns for spinal muscular atrophy, and career advice on when to leave a job in neurology.  In this week's podcast, Neurology Today's editor-in-chief discusses new thinking about functional neurologic disorders, the benefits of screening newborns for spinal muscular atrophy, and career advice on when to leave a job in neurology.   Brain aneurysm rupture, COVID-19 exposure in utero, socioeconomics and brain development. Brain aneurysm rupture, COVID-19 exposure in utero, socioeconomics and brain development. Thu, 21 Jul 2022 09:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses RAAS inhibitors for brain aneurysm rupture, the impact of COVID-19 on babies exposed in utero, and how socioeconomic status, independent of genetics, affects brain development.  

]]> In this week's podcast, Neurology Today's editor-in-chief discusses RAAS inhibitors for brain aneurysm rupture, the impact of COVID-19 on babies exposed in utero, and how socioeconomic status, independent of genetics, affects brain development.

]]> 04:49 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses RAAS inhibitors for brain aneurysm rupture, the impact of COVID-19 on babies exposed in utero, and how socioeconomic status, independent of genetics, affects brain development.  In this week's podcast, Neurology Today's editor-in-chief discusses RAAS inhibitors for brain aneurysm rupture, the impact of COVID-19 on babies exposed in utero, and how socioeconomic status, independent of genetics, affects brain development.   Monkeypox, soticelstat for epilepsy, gabapentin for stroke recovery. Monkeypox, soticelstat for epilepsy, gabapentin for stroke recovery. Thu, 07 Jul 2022 09:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses what's known about monkeypox, soticelstat as a potential new epilepsy therapy, and the potential of gabapentin for stroke recovery.  

]]> In this week's podcast, Neurology Today's editor-in-chief discusses what's known about monkeypox, soticelstat as a potential new epilepsy therapy, and the potential of gabapentin for stroke recovery.

]]> 04:53 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses what's known about monkeypox, soticelstat as a potential new epilepsy therapy, and the potential of gabapentin for stroke recovery.  In this week's podcast, Neurology Today's editor-in-chief discusses what's known about monkeypox, soticelstat as a potential new epilepsy therapy, and the potential of gabapentin for stroke recovery.   Fenfluramine for LGS, social isolation and dementia risk, neurology's status in NRMP match. Fenfluramine for LGS, social isolation and dementia risk, neurology's status in NRMP match. Thu, 16 Jun 2022 09:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses the approval of fenfluramine for Lennox-Gastaut syndrome, how social isolation affects dementia risk, and the competitiveness of neurology in this year's residency match.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses the approval of fenfluramine for Lennox-Gastaut syndrome, how social isolation affects dementia risk, and the competitiveness of neurology in this year's residency match.

]]> 04:56 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses the approval of fenfluramine for Lennox-Gastaut syndrome, how social isolation affects dementia risk, and the competitiveness of neurology in this year's residency match.In this week's podcast, Neurology Today's editor-in-chief discusses the approval of fenfluramine for Lennox-Gastaut syndrome, how social isolation affects dementia risk, and the competitiveness of neurology in this year's residency match. Teleneurology in rural America, trauma-informed neurology,advances in neurogenetics Teleneurology in rural America, trauma-informed neurology,advances in neurogenetics Thu, 02 Jun 2022 09:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses the challenges and opportunities of teleneurology in rural areas, the effect of childhood trauma on neurologic disorders, and genetics advances in neurology.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses the challenges and opportunities of teleneurology in rural areas, the effect of childhood trauma on neurologic disorders, and genetics advances in neurology.

]]> 05:10 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses the challenges and opportunities of teleneurology in rural areas, the effect of childhood trauma on neurologic disorders, and genetics advances in neurology.In this week's podcast, Neurology Today's editor-in-chief discusses the challenges and opportunities of teleneurology in rural areas, the effect of childhood trauma on neurologic disorders, and genetics advances in neurology. Portable MRI for stroke, SSRIs and seizure risk in neonates, neurology training in Ukraine. Portable MRI for stroke, SSRIs and seizure risk in neonates, neurology training in Ukraine. Thu, 19 May 2022 09:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses portable low field MRI for stroke, SSRI exposure in pregnancy and risk for seizures in neonates, and disrupted neurology training in Ukraine.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses portable low field MRI for stroke, SSRI exposure in pregnancy and risk for seizures in neonates, and disrupted neurology training in Ukraine.

]]> 05:08 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses portable low field MRI for stroke, SSRI exposure in pregnancy and risk for seizures in neonates, and disrupted neurology training in Ukraine.In this week's podcast, Neurology Today's editor-in-chief discusses portable low field MRI for stroke, SSRI exposure in pregnancy and risk for seizures in neonates, and disrupted neurology training in Ukraine. Blood pressure trajectories, Parkinson's risk factors, neurology residents, Potamkin Award Blood pressure trajectories, Parkinson's risk factors, neurology residents, Potamkin Award Thu, 05 May 2022 09:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses the link between blood pressure trajectories in young adults and cerebral lesions in midlife, early risk factors for Parkinson's, a newly matched neurology resident, and the winner of the Potamkin Award.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses the link between blood pressure trajectories in young adults and cerebral lesions in midlife, early risk factors for Parkinson's, a newly matched neurology resident, and the winner of the Potamkin Award.

]]> 05:13 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses the link between blood pressure trajectories in young adults and cerebral lesions in midlife, early risk factors for Parkinson's, a newly matched neurology resident, and the winner of the Potamkin Award.In this week's podcast, Neurology Today's editor-in-chief discusses the link between blood pressure trajectories in young adults and cerebral lesions in midlife, early risk factors for Parkinson's, a newly matched neurology resident, and the winner of the Potamkin Award. Gabapentin as a controlled substance embolic stroke of undetermined source, how to become a clinician educator Gabapentin as a controlled substance embolic stroke of undetermined source, how to become a clinician educator Thu, 21 Apr 2022 09:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses the pros/cons of gabapentin as a controlled substance, recurrent stroke risk in adults with embolic stroke of unknown source, how to become a clinician educator.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses the pros/cons of gabapentin as a controlled substance, recurrent stroke risk in adults with embolic stroke of unknown source, how to become a clinician educator.

]]> 04:57 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses the pros/cons of gabapentin as a controlled substance, recurrent stroke risk in adults with embolic stroke of unknown source, how to become a clinician educator.In this week's podcast, Neurology Today's editor-in-chief discusses the pros/cons of gabapentin as a controlled substance, recurrent stroke risk in adults with embolic stroke of unknown source, how to become a clinician educator. Neurologists in Ukraine, neurology costs discussions, statins and parkinsonism Neurologists in Ukraine, neurology costs discussions, statins and parkinsonism Thu, 07 Apr 2022 09:00:00 +0000 In this week's podcast, Neurology Today's editor-in-chief discusses the link between statins and parkinsonism, how neurologists in Ukraine are faring, why and how to discuss the costs of care with patients.

]]> In this week's podcast, Neurology Today's editor-in-chief discusses the link between statins and parkinsonism, how neurologists in Ukraine are faring, why and how to discuss the costs of care with patients.

]]> 05:28 false full American Academy of Neurology Neurology TodayIn this week's podcast, Neurology Today's editor-in-chief discusses the link between statins and parkinsonism, how neurologists in Ukraine are faring, why and how to discuss the costs of care with patients.In this week's podcast, Neurology Today's editor-in-chief discusses the link between statins and parkinsonism, how neurologists in Ukraine are faring, why and how to discuss the costs of care with patients.